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ABSTRACT 
 
Information at the protein level is essential to understand the functioning of a biological 
system. The goal of proteomics is to provide such information as protein identities, post-
translational modifications (PTMs) on proteins, and ultimately, quantification of proteins or their 
PTM levels from given biological samples, mostly using mass spectrometry. Modern mass 
spectrometry-based proteomic analyses primarily fall into two categories in terms of general 
strategies -- the "bottom-up" and "top-down" approaches. Bottom-up proteomics relies upon 
enzymatic protein digestions (mostly by trypsin) prior to on-line liquid chromatography-coupled 
tandem mass spectrometry analysis (LC-MS/MS) of post-digestion peptides. Top-down 
proteomics omits the proteolysis step and directly focuses on the characterization of intact 
proteins and their post-translational modifications. 
While both approaches continue to mature, they each have limitations. In the bottom-up 
approach, tryptic peptides are the primary unit of measurement and are powerful in protein 
identification, but their relatively small size (typically ~8–25 residues long) raises potential 
issues such as significant sample complexity, the “protein inference problem” (i.e. the inability to 
assign an identified tryptic peptide to a specific protein, instead of  a group of proteins sharing 
this tryptic peptide sequence), and loss of PTM and combinatorial PTM information. The top-
down approach handles these issues by characterizing intact proteins, but becomes less 
successful as the protein size increases. Here, a hybrid approach based on restricted proteolysis 
to generate middle-sized peptides (i.e. 2–20 kDa) for mass spectrometry analysis could combine 
positive aspects of both bottom-up and top-down proteomics. 
Although various alternative methods to trypsin digestion have been investigated to 
explore restricted proteolysis options, these previous efforts only lead to the production of 
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peptides marginally longer than tryptic peptides. Here, a digestion method using the outer 
membrane protease T (OmpT) derived from E. coli is developed to achieve efficient yet 
restricted proteolysis, thanks to its selective cleavage primarily between dibasic sites 
(K/R─K/R). In Chapter II, a robust OmpT expression and purification workflow with high 
enzyme yield and purity is depicted. One major obstacle in obtaining active OmpT enzyme is its 
autoproteolysis between Lys217 and Arg218, which causes the protease to become inactive. 
Several tactics are utilized to maintain the intact and active form of OmpT during purification 
and digestion. Thereafter, a set of OmpT digestion conditions are optimized using standard 
proteins as test substrates. 
In Chapter III, the initial demonstration of OmpT digestion on a complex proteome 
sample is described. First, OmpT-based proteolysis is integrated with a size-dependent protein 
fractionation technique, and established a robust middle-down proteomics pipeline. The platform 
is then applied to the analysis of prefractionated high-mass HeLa cell proteome (~20─100 kDa). 
From this initial trial, 3,697 unique OmpT peptides were identified from 1,038 unique proteins. 
These OmpT peptides were larger (>6.3 kDa on average) than those produced by traditional 
proteases, allowing differentiation of closely related protein isoforms and detection of PTMs or 
even multiple PTM combinations on a single OmpT peptide. This is the first report of a protease 
that is not commercially available, yet with insufficient previous knowledge about its protein 
chemistry, but is able to perform highly selective cleavage in an efficient way after extensive 
optimization. 
In Chapter IV, to further validate the efficacy of this novel protease-centered middle-
down platform to deliver biologically meaningful proteome information, the same workflow is 
used to qualitatively compare mouse brain proteomes between two inbred mouse strains. After 
iv 
 
searching the middle-down data against strain-specific databases, 1,934 peptides (average size: 
6.0 kDa) were identified from 714 proteins in the high-mass region of the mouse proteome from 
strain C57BL/6J; 1,855 peptides (average size: 6.0 kDa) were identified from 690 proteins in the 
same high-mass region from strain DBA/2J. Through the comparison of identified OmpT 
peptides, some interesting single nucleotide polymorphism (SNP) examples are found between 
the two strains. These findings verify the robustness and efficacy of the middle-down 
performance in analyzing complex tissue proteomes. With the creation of those strain-specific 
databases and the high-throughput interrogation of mouse brain proteomes using middle-down 
pipeline, a solid foundation has been built for future follow-up comparative studies on cross-
strain differences. 
Chapter V describes the continuation work of the histone biology story initiated by Dr. 
Jihua Jiang. In her previous studies, a strong correlation between histone hyperacetylation state 
and higher survival rates was observed in histone deacetylase (HDAC) mutants than wild type 
yeast upon hydrogen peroxide-induced apoptosis due to DNA damage. Meanwhile, a global 
increase in the phosphorylation level at Ser129 on histone H2A in HDAC mutants was also 
observed after 200 min. hydrogen peroxide treatment. We hypothesized that the hyperacetylation 
in HDAC mutant may help to prevent chromatin condensation, allowing more time for Ser129 to 
be phosphorylated, which would recruit the DNA repair machinery to the DNA damage loci for 
DNA repair, and in turn lead to a higher survival rate. So I developed a protocol to image the 
condensed chromatin in yeast nuclei using transmission electron microscopy (TEM), which 
showed that in HDAC mutant cells less chromatin condensation was observed compared with 
wild type yeast. I also profiled the dynamic changes of all four core histones to illustrate the 
phosphorylation changes along with the acetylation states during the 200 min. time course after 
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hydrogen peroxide induction to apoptosis. My contribution to this project provided further clues 
to uncover the resistance mechanism to H2O2-induced apoptosis in yeast. 
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CHAPTER 1: INTRODUCTION 
 
Acknowledgment: The figures and a small portion of the text were adopted from the paper "A 
protease for 'middle-down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012) with 
modifications. Dr. Leonid Zamdborg performed the in silico digestions and provided the raw 
data for the generation of digested peptide distribution plots. 
 
1.1 - Mass spectrometry-based proteomics -- Bottom up vs. Top down 
1.1.1 - Bottom-up proteomics 
The scope of proteomics involves the investigation of the protein content, PTMs on the 
proteins and quantification of their abundances in a complex matrix. Mass spectrometry (MS) 
offers a great means to achieve this goal because of its robustness, sensitivity and accuracy (1, 
2). Currently, mass spectrometry-based proteomic analysis follows a generic scheme such as: 
front-end sample preparation and separation, online liquid chromatography coupled tandem mass 
spectrometry (LC-MS/MS), and post-acquisition bioinformatic analysis for identification or 
quantification results using various software. Under this general scheme, two major 
methodologies co-exist: the most prevalent bottom-up proteomics (3, 4) and the newly emerging 
top-down proteomics (5, 6). While these two methodologies differ in LC-MS/MS and 
bioinformatics parts, the most significant difference derives from the front end (7, 8). 
In bottom-up approach, samples of interest, either a complex protein mixture or a 
relatively simple set of proteins after some sample enrichment (e.g. immunoprecipitation, epitope 
tag pull-down, etc.), are subjected to enzymatic digestion before LC-MS/MS. A pool of 
proteases can be used here, trypsin being the most popular one; additionally, Lys-C (4), Lys-N 
(9, 10), Asp-C and Asp-N have also been explored and implemented for sample proteolysis (11, 
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12). Therefore, the resultant peptides serve as the basic unit for MS measurement; proteins that 
contain the identified peptide sequences are then retrieved as identifications. Prior to online LC-
MS/MS characterization, the digested peptide mixture may undergo several dimensional 
separations (13), such as isoelectric focusing (IEF) or ion exchange to further reduce the 
complexity of peptides prior to the online LC-MS/MS analysis. 
Depending on the type of instrument available, the data collection method varies. Modern 
hybrid instruments, with a front-end linear ion trap (LTQ) or a quadrupole and a back-end high-
resolution Fourier Transform (FT) mass analyzer (e.g. Fourier Transform ion cyclotron 
resonance (FT-ICR) (14) and orbitrap (15)), have gained popularity recently for such large scale 
high-throughput proteomic studies (e.g. LTQ-FT, LTQ-Orbitra, Q Exactive, etc.) (16-22). On 
such instruments, survey scans occur in the back-end high-resolution FT mass analyzer in order 
to obtain high-resolution precursor spectra for the deduction of high-mass-accuracy peptide 
masses (± 10, or 5 ppm) (23, 24). This high mass accuracy benefits the database searching part 
by narrowing down the number of candidates from the target database thanks to a more stringent 
precursor tolerance window (23). Because the size of the peptide analytes is smaller than 2 kDa 
on average, the unit-resolution ion trap can serve well to differentiate those that are doubly or 
triply charged peptide fragment ions. Hence, tandem mass spectra are scanned in the linear ion 
trap. This minimizes the required time per identification event, thus enabling very higher 
sequencing speed. 
OMSSA, Mascot and Sequest are the commonly used MS/MS data search engines for 
"high-low" experiments (i.e. survey scans in high-resolution analyzer and fragmentation scans in  
unit-resolution ion trap) (25-29). False discovery rate is introduced to evaluate the quality of the 
collected data set (30, 31). To estimate the false discovery rate of peptide hits from the forward 
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database search, a reverse or decoy database search strategy can be applied (6, 31, 32) where the 
sequences in the forward database are reversed or shuffled, and then searched against for false 
positive hits, which will also be scored and ranked along with forward (or true positive) hits. 
Then a score cut-off is set, where the number of false positive hits (hits from reverse or decoy 
database search) that make the cut-off take up to 1% of the total hits. Supposing that  proteins 
identified with two peptide hits, such identifications are regarded highly confident, as in this 
case, the theoretical false positive rate for protein identifications would be 1 × 10
-4
 (=0.01
2
). 
Because of the robustness of trypsin digestion and the ease to separate and identify tryptic 
peptides, bottom-up approach has a broad spectrum of applications in multiple areas in that 
bottom-up approach serve as such a high-throughput and effective tool for protein identification, 
since only a couple of tryptic peptides are needed for one protein identification. A few examples 
are listed in detail as below. 
Due to its compact structure in the active form, trypsin is not only applied to in-solution 
digestion, but also in-gel digestion (33, 34), where trypsin gets into SDS-PAGE gel mesh and 
chews off the proteins separated in a 1-D slab gel. The generated tryptic peptides will dissolve 
into extraction solution for further MS analysis. Because of the compatibility of in-gel digestion 
with SDS-PAGE, proteins of interest can be separated and virtualized first using reversible 
staining procedures, followed by incision of the gel slice containing the visualized target proteins 
and trypsin digestion, which significantly facilitates the specificity of the downstream MS 
analysis and reduce sample complexity. In-gel digestion now has become a benchmark technique 
routinely practiced in proteomics labs and gives a large number of identifications. 
At the same time, a variety of quantitative techniques, such as label free spectral counting 
(35, 36), isobaric tags for relative and absolute quantitation (iTRAQ) (37), stable isotope labeling 
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by amino acids in cell culture (SILAC) (38) and so forth, have been developed to couple with 
bottom-up approach for quantitive proteomics (with some concerns with the bias from proteases 
recently, discussed further below). Triple quadrupole-based instruments have become the gold 
standard for targeted quantitative proteomics (39, 40). Depending on the nature of the analysis, 
different considerations need to be taken into account when choosing a quantitative strategy (41). 
Furthermore, through specifically designed enrichment protocols, a subset of tryptic 
peptides harboring a certain type of modification, such as phosphorylation, can be investigated in 
great detail (42, 43). In phosphoproteomics (44), phosphorylated tryptic peptides are enriched by 
anti-phospho (mostly antiphosphotyrosine) antibodies, immobilized metal affinity 
chromatography, strong cation exchange or titanium dioxide chromatography. Then the enriched 
modified peptides are analyzed by bottom-up approach. Similar strategies have also been used 
for proteome-wide analysis of several other PTMs, including acetylation, glycosylation (45) and 
ubiquitination (46). 
Additionally, an array of chemical crosslinkers have been developed to covalently react 
with and connect two spatially close amino acid side chains, either from the same protein or 
different proteins. Upon trypsin digestion, those crosslinked part will form an "H"-shaped 
peptide, with two tryptic peptide tethered together by the crosslinker, The identification of such 
"H"-shaped peptides will provide protein structure information and reveal possible interacting 
protein partners (47). Bottom-up approach has many other applications which will not be 
articulated  here. 
However, in spite of its broad and useful applications, bottom-up approach does have its 
drawbacks. After enzymatic digestion, the molecular weight of resultant peptides is usually 
below 2 kDa; in the case of tryptic peptides, their length mostly ranges between 8-25 amino acid. 
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While such small peptides are indeed easier to solubilize, separate, ionize and fragment 
compared with intact proteins, the small size also gives rise to a series of issues. 
First of all, a huge sample complexity will be introduced upon trypsin digestion, 
especially when a complex proteome sample is being analyzed. For example, one protein can be 
digested into multiple tryptic peptides, and in a complicated proteome sample, there usually are 
tens of thousands of proteins, so the complexity of the resultant peptides increase exponentially 
after trypsin digestion. Even with multiple front-end separations, the current the state-of-the-art 
instruments are still not fast enough to sequence all of the tryptic peptides co-eluted off the LC. 
A concomitant effect is a relatively low sequence coverage by identified tryptic peptides. 
Although this number varies significantly, in a typical complex proteome study, the protein 
sequence coverage falls below 30%. 
Second, still because of the relatively small peptide size, "protein inference problem" can 
happen(48, 49). Multiple protein forms can be derived from a single gene product, due to, for 
example, alternative splicings at mRNA level, or post-translational processing at protein level. 
These protein forms resemble each other to a large extent with only some slight difference in a 
small portion of their sequences. Furthermore, even proteins from different gene products but the 
same gene family or with similar biological functions may have partial or overall similar 
sequence. So in bottom-up studies, it is not rare to observe a tryptic peptide, whose sequence is 
shared among a group of proteins, making the assignment of such peptides to a specific protein 
or protein isoform difficult. But such information as specific protein or protein isoform may be 
indicative of interesting and important biological functions in the sample of interest. 
Consequently, this "protein inference problem" limits the depth of biological information 
bottom-up approach can provide. 
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Third, PTM information may get lost in bottom-up proteomics (48, 49). To start with, the 
relatively low sequence coverage implies that some modified tryptic peptides may not even be 
identified. Furthermore, there may be a combination of multiple PTMs on a single protein, but 
upon digestion, such combinatorial PTM pattern is disconnected and individual PTMs more 
likely than not end up on separate tryptic peptides. But the "on" and "off" those PTMs can signal 
a specific type of biological readout, for instance, histone code (50, 51). This type of information 
is biologically important, but significantly lost. A topic that is not covered here is the 
inefficiency of bottom-up search engines to take advantage of our already established knowledge 
of PTMs to identify modified tryptic peptides, particularly in a discovery mode. 
Lastly, all types of proteomic analysis that involve protease digestion in the front-end 
sample preparation are subject to the bias introduced by the protease used (49, 52). Such concern 
has been addressed recently. Depending on the substrate specificity of the protease, proteins 
containing less protease cleavage sites are biased against in contrast to those that contain more 
such sites and which can be digested more readily. For example, trypsin digestion may work well 
on positively charged or hydrophilic regions of proteins, but not on hydrophobic regions of 
proteins (one of the reasons why membrane proteins are biased against in bottom-up studies). 
Such bias from proteases is a major concern especially in quantitative proteomics. 
 
1.1.2 - Top-down proteomics 
Top-down approach differs from bottom up most in the front-end sample preparation. 
The idea is to omit the proteolysis step as in bottom up and to focus straight on the complete 
characterization of intact protein molecules, as well as their PTMs. 
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Unlike various separation toolkits well established in bottom up, approaches to separate 
large proteins in solution phase are more limited. Recently, GELFrEE (gel-eluted liquid fraction 
entrapment electrophoresis) (53, 54) has been developed to fractionate proteome samples in 
solution phase based on proteins' molecular weights, and to successfully couple to top-down 
proteomics. In particular, GELFrEE technique is so useful to top down that it boosts the number 
of identifications by over 10 fold compared to previous top-down studies. Thanks to GELFrEE, 
both LC and MS settings and fragmentation methods (e.g. collision-induced dissociation, or CID, 
electron transfer dissociation, or ETD (55, 56), high-energy collision dissociation, or HCD) can 
be tailored according the mass range of proteins in a given GELFrEE fraction (57). 
The settings of reverse phase columns and gradients have also been optimized for top-
down online LC separation (58), which, not surprisingly, dramatically differs from bottom-up 
parameters. For the MS measurement, due to the large size of protein fragments in gas phase, ion 
trap can no longer differentiate their charge states; thus, the tandem mass spectra are also 
collected in the high-resolution analyzers, for which such data acquisition strategy is termed as 
"hi-hi" experiments (i.e. both the precursor and fragmentation spectra are in high resolution) 
(59), as opposed to "hi-low" experiments in bottom up. As far as fragmentation options, 
depending on the nature of the experiments and the size of proteins, several methods can be used, 
including CID, ETD and HCD as mentioned above.  
ProSightPC, developed by Kelleher group, is widely used search engine for hi-hi data 
(60, 61). Monoisotopic masses of both intact proteins and fragments are determined using 
algorithms such as THRASH (62-65) or Xtract; the precursor mass along with its corresponding 
fragment masses are compiled into an "experiment", which is the basic unit for database 
searching. Uniprot databases are downloaded, along with known PTM information (2) to create 
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ProSight databases for database retrieval. Because the fragment spectra are collected in high 
resolution, accurate fragment masses can be calculated. In this case, only a few high-mass-
accuracy fragments are needed to confidently identify a protein (66). This also enables large 
error-tolerance window search, which can potentially identify unknown PTMs, although manual 
verification is required for confirmation eventually. 
Currently, although bottom-up method is still superior in terms of sheer number of 
protein identifications and throughput, top-down method has undergone intensive development 
and significant improvement to catch up in large scale proteomic studies. More importantly, top 
down can provide biologically meaningful information that is highly complementary to bottom 
up regarding several aspects. 
First, top down gives gene-specific or even isoform-specific identifications, since 
accurate intact protein mass information is acquired (67, 68). This circumvents the protein 
inference problem in bottom up. In the meantime, thanks to the error-tolerant searching, proteins 
with large unknown mass shifts, such as SNPs, truncations, insertions or unknown PTMs can be 
identified. Finally, all PTMs on a intact protein, as well as their relative intensities, are preserved 
and characterized simultaneously after searching against UniProt database with annotated 
modifications, if enough protein backbones are cleaved for PTM localization during gas-phase 
fragmentation. Because of the reasons above, top down proteomics initially gained popularity 
quickly in characterizing abundant proteins with multiple modifications, like histones (69, 70), 
HMGs (6) and so on. Also, there are ongoing efforts to characterize membrane proteins using top 
down, which has been hard-to-access area by protease-based bottom up approach. 
The major issue in top down is that, while top down is doing a decent job in the low-mass 
regime of a proteome, its performance deteriorates severely as proteins get larger, albeit 
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tremendous advancement has been made to elevate the upper detection limit of protein mass 
accessible to MS detection (71). 
Several factors contribute to the difficulty in detecting large proteins. To begin with, 
before protein analytes get into MS, the sample separation poses a great challenge. Although 
GELFrEE has lowered down the sample complexity noticeably, the online LC part couldn't 
separate large intact proteins as effectively as small peptides and peak broadening is quite 
significant, diluting signals in MS. Also, the ionization efficiency also becomes lower as the 
protein size increases.  
After ionized protein species manage their way into MS, the number of charge states 
surpassed that of tryptic peptides dramatically, causing a diluted signal of one protein species 
into different m/z channels (72). At the same time, natural isotopes (mainly 
13
C and 
15
N) will 
further complicate the isotopic distributions and decrease the signal-to-noise (S/N) ratio along 
the increase of protein molecular weight (72). Moreover, as the charge states increase, the 
distance between adjacent isotopic peaks within an isotopic distribution becomes narrower (1/z) 
on the m/z axis, and will eventually reach the resolution limitation of instruments, causing 
isotopic peak coalesce (14), thus the inability to calculate the charge state based on isotope-
peaks-resolved spectra. Finally, large proteins are harder to fragment. Besides above, a topic 
about the dynamic range of top down has not been systematically investigated to my knowledge, 
but it is suspected that the dynamic range of top down is concerningly narrower than smaller-
peptide-centric bottom up, in spite of the fact that the dynamic range of FT-ICR and orbitrap 
(~10
3
, (73)) is already orders of magnitudes lower than those of protein abundances in a complex 
proteome sample (~10
6
). 
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There are also some other issues for intact protein-based top down method, just to 
mention a few briefly here. Large intact proteins are easier to get attached by artificial adducts, 
such as phosphates, sodium or potassium ions, SDS and acrylamide (during GELFrEE for 
example, but reduction and alkylation of cysteine side chains can prevent the acrylamide 
adducts) and so forth. A pertinent issue is inevitable oxidation of methionine in large proteins, 
which causes a 16+ Da mass shift, complicates the mass spectra and makes quantification hard. 
In addition, the possibility of having interfering species also increases with masses. On the other 
hand, the requirement of coupling to online LC favors water-soluble proteins; proteins with poor 
solubility in reverse phase separation probably will be biased against (similar issue to 
hydrophobic tryptic peptides). Also, in source fragmentation of intact proteins may happen, 
particularly when an ion optics offset voltage (SID voltage) is applied. 
It should be noted that a vast array of efforts are being poured into each individual 
frontier of the issues mentioned above for improvement or solutions. To just name a few, efforts 
to develop capillary electrophoresis for online intact protein separation and to couple it with 
electrospray ionization (ESI)-based MS are underway (indeed, capillary isoelectric focusing 
(CIEF)-ESI has been published a long time ago (74)), which hopefully can handle a lower 
sample loading amount and provide improved separation and sensitivity. Intelligent custom 
software are being developed to automatically choose which fragmentation method to use 
(among CID, ETD and HCD) based on user-defined purpose of the analysis and to use the 
instrument time more effectively by selecting the ideal precursors for fragmentation. 
Supercharging is another area where methods are being developed to concentrate the charge 
states of intact proteins to just only a few highly charged species, thus enhancing the signal 
intensity of each m/z channel, plus the fact that higher charge states are beneficial to 
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fragmentation as well. External ion accumulation devices have been built to pool more ions for a 
single survey or fragmentation scan in FT-ICR for a boost in S/N level (75, 76). 
 
1.2 - Restricted proteolysis and middle-down proteomics 
As exciting improvements are being made at both bottom-up and top-down frontiers to 
push the performance limitations of both further beyond, an intermediate method that marries the 
positive aspects of both methods can clearly help to expand the scope of mass spectrometry-
based proteomics. In other words, a novel method to perform restricted proteolysis, which has a 
narrower substrate specificity and makes fewer cleavages in the proteome than currently 
available proteases, needs to be devised. This method should be able to convert large intact 
proteins beyond the detection limit into peptides accessible to top down; meanwhile, it should 
also be able to generate peptides larger than those produced by traditional proteases, so that less 
peptides will be generated in total, reducing the sample complexity upon digestion. Hopefully 
larger peptides will have a higher chance to harbor PTMs and a combinations of PTMs and to 
lead to isoform-specific protein identifications by covering the unique sequence region of a 
specific gene-product. 
It is noteworthy that because the resultant peptides would be larger after restricted 
proteolysis, unit-resolution ion trap cannot resolve the highly charged fragment ions. 
Accordingly, a hi-hi strategy is needed to characterize such large peptides. This means that the 
data acquisition and bioinformatic analysis sections will follow the downstream of top down 
pipeline described above. Regarding the front-end sample preparation, GELFrEE provides robust 
molecular weight-based intact protein separation and top down is actually doing a great job in 
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the low mass regime of a proteome, the restricted proteolysis seems particularly useful to tackle 
the formidable high-mass regime from the top-down perspective. 
Kelleher group previously proposed a generic approach to "middle-down" proteomics 
(77), with two essential features -- a size-dependent fractionation, which has been achieved 
through GELFrEE technique, and a method to perform restricted proteolysis. The idea was that 
after proteome fractionation by GELFrEE, top down handles the low-mass region of the 
proteome and middle-down the high-mass region. But it ought to be pointed out that such 
restricted proteolytic method, once developed, does not have to be coupled to GELFrEE, because 
one can apply it to the digestion of any type of protein samples, just like the way trypsin and 
other proteases are used. In this study, this restricted proteolytic method is combined with 
GELFrEE because of our strong interest in high-mass proteomes. 
Indeed, there have been quite a few initial efforts to explore restricted proteolytic options 
using Glu-C, Lys-C or Asp-N to produce larger peptides and preserve multiple PTMs for the 
targeted proteomics (51, 69, 78-80), while later efforts on the proteome-scale have employed 
Lys-C or Lys-N digestions (81, 82). Nonetheless, these enzymes produce peptides only 
marginally longer than tryptic peptides in large-scale proteomic studies, offering limited 
improvement in peptide size. Regarding alternative chemical methods, microwave-assisted acid 
hydrolysis generated peptides in the 3–10 kDa range with selective cleavage at aspartic acid 
residues. This approach improved ribosomal proteome coverage, but the peptides produced were 
still relatively small (average: 3.2 kDa) (83-87). 
In summary of this section, a means for robust and restricted proteolysis is clearly needed 
and beneficial, but there hasn't been significant breakthroughs in this regard up until this study. 
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1.3 - Outer membrane protease T (OmpT) 
I set out searching for possible ways to realize robust and restricted proteolysis when I 
took on the project. Several criteria need to be considered in search of such method. First, it 
should have a narrower substrate specificity than currently widely used enzymes. It is preferred 
to have a substrate recognition motif of two consecutive amino acids instead of a single amino 
acid residue, so that it will make less frequent cleavages in the proteome and produce larger 
peptides. 
Second, this restricted methods should possess highly efficient proteolytic activity, 
ideally comparable to trypsin, for the reason that a small amount of enzyme is preferred when 
analyzing limited samples to avoid an overwhelming enzyme peak during LC-MS. Also, 
sometimes the protein concentration in the digestion system might be low; therefore, efficient 
enzyme is desired to completely digest and deplete protein substrates in a broad range of 
substrate concentrations. 
Third, resistance to high-concentration denaturant is probably required. Trypsin chews up 
proteins even in a low concentration of denaturant by disintegrating protein chunks after the 
digested tryptic peptide come off and get dissolved into solutions, because trypsin recognition 
sites (single lysine and arginines, except when proceeded by a proline and sometimes aspartate 
or glutamate) are ubiquitous among proteins. However, this restricted method probably requires 
complete denaturation of protein substrates to ensure a complete digestion, in that such rarer 
cleavage sites may not be well exposed or linearized in the digestion system due to proteins' 
three-dimensional conformation, thus inaccessible for digestion, unless a high-concentration 
denaturant is applied. And this requires a demanding stability of this method in greatly 
denaturing conditions. 
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Additionally, there are several advantages of enzymatic approaches over chemical 
methods. For instance, chemical methods, such as cyanogen bromide (CNBr) for cutting C-
terminus of methionine residues (88-90) and BNPS-Skatole for cleaving C-terminus of 
tryptophan residues (91, 92), seem less attractive in terms of stringent substrate specificity, 
proteolytic robustness and efficiency and introducing minimal side reactions such as oxidation 
and desulfurization. So proteases are preferred candidates than chemical methods. 
With the major screening criteria above, the outer membrane protease T (OmpT), was 
selected to serve as the “rare-cutting protease”. 
The uttermost reason to choose OmpT is that it has been reported to specifically cleave 
between di-basic amino acid residues (93, 94) -- a narrower substrate specificity than trypsin. An 
in silico digest of human proteome was performed to visualize the peptide size distribution using 
different proteolytic methods, including trypsin, OmpT, Lys-C, Glu-C, Asp-N, Arg-C, and CNBr 
(Figure 1.1a). Most of the traditional enzymatic approaches (trypsin, Lys-C, Arg-C, Glu-C, Asp-
N), especially trypsin, produce predominantly small peptides (<2 kDa), indicating a potentially 
significant sample complexity when digesting protein mixtures. Intriguingly, OmpT, assuming it 
specifically cleaves less frequent di-basic sites, produces an order of magnitude fewer small 
peptides (another set of substrate specificity is assumed and will be discussed later in Chapter 
III). The number of peptides that result from traditional digestion methods decrease noticeably as 
peptide mass increases. In contrast,  the number of "OmpT peptides" starts to exceed the other 
enzymes around 3 kDa and maintains reasonably high frequencies of peptide fragments up to 30 
kDa, suggesting a longer peptide length on average and hopefully more biological information 
preserved in these peptides. All enzymes, whether OmpT or trypsin misses some predicted 
cleavage sites; hence, another in silico digestion was performed with 2 missed cleavages (Figure 
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1.1b) and represented a similar pattern to the 0 missed cleavages. As a result, the ability of 
OmpT to produce larger peptides has been investigated and validated via in silico digest. 
Equally important, with trypsin having a reported substrate-dependent kcat/Km in the order 
of 10
6
-10
7
 (95-97), OmpT shows a comparable kcat/Km, ranging from 2x10
4
 to 1x10
8
 s
-1
M
-1
, with 
significant heterogeneity because of the diversified substrates (98-102) -- a comparable catalytic 
efficiency to trypsin. 
On the other hand, OmpT is endowed with ten anti-parallel structure beta-sheet structure 
that renders it impressively resistant to chaotropic reagents, (e.g. even up to 4 M urea) (101, 
103). An inclusive list of all the benefits of this protease for robust and restrict proteolysis are 
discussed in further detail in Box 1.1, thanks to the vast and precious knowledge pool about the 
properties of this protease that has been accumulated and published in previous literature. 
OmpT was derived from Escherichia coli outer membrane and lipopolysaccharide (LPS) 
is required for the activity of OmpT (100, 104, 105). OmpT was initially classified as serine 
endopeptidase (106), but further homology analysis later classified its novel protease family, the 
omptins (107). There are four other members of omptin family: PgtE of Salmonella 
typhimurium, (49% identity to OmpT); Pla of Yersinia pestis (50% identical), SopA of Shigella 
flexneri (60% identical), and OmpP of E. coli (72% identical) (100). Although OmpT was 
considered to be associated with the degradation of many recombinant proteins expressed in E. 
coli in vitro (103, 108, 109), its biological function in vivo remains to be fully explored. 
Although there have been some literature reports about the utilization of OmpT to cleave 
target sequences in a protein linker region or short peptide sequences (110-112), no one has 
published attempts to utilize OmpT for the large scale proteome digestion. In this thesis, I 
discussed my work to develop OmpT into a useful and efficient reagent to yield > 2 kDa peptides 
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and apply OmpT-based middle-down proteomics to the analysis of HeLa cell and mouse brain 
issue proteomes. In the HeLa study, some proof-of-concept examples are shown to illustrate the 
abilities of OmpT to differentiate closely resembled protein isoforms and to preserve multiple 
PTMs on a single peptide. In the mouse brain proteome comparison work, interesting targets are 
found to harbor unique SNPs to a specific mouse strain, which demonstrates the efficacy of 
middle-down approach to probe real biological samples. 
31 
 
1.4 - Figures and Notes 
 
Figure 1.1: In silico digestions of human proteome with assorted proteolytic methods 
assuming 0 and 2 missed cleavages with two sets of OmpT cleavage rules (K/R-K/R and 
K/R-K/R/A/S). (a) CNBr, cyanogen bromide, cleaves after methionine. OmpT1 is set to cleave 
between di-basic sites (P1 = K, R; P1' = K, R); OmpT2 assumes basic amino acid residues at P1 
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Figure 1.1 (cont.) as OmpT1 but also allows alanine and serine in addition to basic amino acid 
residues at P1' site (P1 = K, R; P1' = K, R, A, S). All proteolytic methods assume 0 missed 
cleavage. (b) Cleavage rules are the same as a. All proteolytic methods assume up to 2 missed 
cleavages. This figure is adopted from the paper "A protease for 'middle-down' proteomics", Wu, 
C., et al. Nat. Methods. 9, 822-824 (2012) with modifications. 
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Box 1.1: Favorable OmpT properties for robust and but restricted proteolysis. 
Narrower substrate specificity than trypsin. OmpT primarily cleaves between dibasic sites, 
rather than single basic sites as does trypsin (93, 94, 106, 113). The P1 position of the OmpT 
recognition sites are almost exclusively lysine or arginine. Studies suggest that in addition to 
lysine and arginine residues, several other minor amino acid residues such as alanine are also 
allowed in its P1' position, especially under denaturing conditions (111). Regardless, the overall 
substrate specificity of OmpT is more stringent than trypsin. 
High proteolytic activity. The catalytic efficiency of OmpT is substrate-dependent and its 
kcat/Km ranges from 10
4
 to 10
8
 s
-1
M
-1
 (94, 98, 99, 102, 110). The highest reported kcat/Km of 
OmpT is 1 × 10
8 
s
-1
M
-1
, when a fluorogenic tetrapeptide, Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 
(Abz, o-aminobenzoyl; Tyr(NO2), 3-nitrotyrosine), was used as the substrate (100). For 
reference, trypsin has a kcat/Km between 10
6–107 s-1M-1 (95-97, 114). 
Active in denaturing conditions. Denaturants are required to expose the buried potential OmpT 
cleavage sites because of three-dimensional structures in protein substrates to the enzyme for 
complete digestion. Owing to its rigid 10-stranded antiparallel beta-barrel structure (101), OmpT 
completely degrades recombinant proteins even in the presence of 4 M urea (103). 
Compatibility with detergents. OmpT itself is a membrane protein and therefore requires 
detergents to remain soluble and maintain its active structure. OmpT has been shown to be 
compatible with zwitterionic, nonionic and anionic detergents (100). 
Easy to express and purify. Large amounts of active OmpT enzyme can be readily obtained 
through expression in the form of inclusion bodies and in vitro refolding (100). The active 
enzyme can reach very high purity after one-step purification. 
Optimal pH close to neutral. A close-to-neutral optimal pH is preferred because extreme pH 
conditions may bias digestion against basic or acidic protein substrates. The optimal pH for 
OmpT activity is close to neutral, around 6.0-6.5 (100, 106). 
 
This box is mainly adopted from the paper "A protease for 'middle-down' proteomics", Wu, C., 
et al. Nat. Methods. 9, 822-824 (2012) with modifications. 
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CHAPTER 2: ESTABLISHMENT OF THE OMPT PURIFICATION WORKFLOW AND 
OPTIMIZATION OF OMPT DIGESTION CONDITIONS FOR ROBUST AND 
RESTRICTED PROTEOLYSIS 
 
Acknowledgment: A small portion of the text and figures were adopted from the paper "A 
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2.1 - Introduction 
I learned this significant trend early in my Ph.D. that the number of publications versus 
time spent does not follow a linear, but an exponential curve. It looks a lot like the lag and log 
phases of an E.coli growth curve, where it stays low at the beginning but skyrockets 
exponentially after a certain period of latency. But as far as how long exactly the lag phase will 
be (or say the down/depressing period a person will have to endure or suffer or brave through), it 
varies dramatically, depending on the projects people will be working on; sometimes, it takes 
only months, but other times, it takes years, or many many years. In my case, the lag phase was 
about three years. 
The most important reason why it took me three years of down time to see the first beam 
of light indicating there was indeed a hope for publication is that a major hurdle had been 
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preventing me from getting active OmpT enzyme -- OmpT self-degradation issue, which is the 
first focus of this introduction and makes this chapter the essential one of the whole middle-
down story. OmpT is reported to cleave di-basic sites (Lys-Lys, Lys-Arg, Arg-Arg, Arg-Lys). 
There are three di-basic sites within OmpT sequence itself, Arg37-Lys38, Lys217-Arg218 and 
Lys259-Lys260. The Lys217-Arg218 auto-cleavage (the numbering of amino acids starts from 
the first amino acid after the signal peptide is removed) has been observed and reported before; 
the auto-cleavage of Lys217-Arg218 inactivates OmpT (1). This is probably because this di-
basic site is located on a flexible loop on top of the beta-barrel structure, thus perhaps more 
exposed and susceptible to self-degradation than other two sites, which are located on the body 
of the barrel (2). 
My efforts to overcome this self-degradation issue will be described in great detail below, 
but as a starter, I will introduce two OmpT expression and purification strategies, based on 
previous literature, since this protease is not commercially available and I needed to express and 
purify it myself. One stategy is that OmpT gene was cloned into expression vector and expressed 
in full length with the first 20-amino-acid-long signal peptide, which serves to localize newly 
synthesized OmpT to E.coli outer membrane. Then OmpT was extracted from E.coli outer 
membrane and further purified (3, 4). Nonetheless, this strategy involves tedious multiple 
purification steps and other membrane proteins were usually co-purified with OmpT. Therefore, 
another strategy was devised to obtain OmpT in large quantity and higher purity. In the second 
strategy, the first 20 amino acids of OmpT sequence were deleted from the expression vector and 
the expression of OmpT was induced by the addition of high concentration of isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 37°C (1). Under these conditions, OmpT was expressed in the 
form of inclusion bodies in large amounts. Then OmpT inclusion bodies were isolated, 
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resolubilized and refolded into active form in vitro (1, 5). The second strategy has several 
advantages over the first one. First, inclusion bodies expression enables OmpT production in 
great quantity. Second, isolation of inclusion bodies is relatively easy and avoids co-purification 
of other membrane proteins. Third, the isolated inclusion bodies were already acceptably pure 
(1), so only very few extra steps were needed for further purification. Therefore, the second 
strategy was adopted in this study to produce OmpT enzyme. 
As mentioned earlier, OmpT suffers from auto-cleavage and it started right after its 
refolding into active form after inclusion body resolubilization and up to 55% of OmpT was 
reported to be auto-cleaved after purification (1). This was why in the literature that originally 
developed this in vitro folding strategy, a mutant form of OmpT (G216K/K217G) was actually 
used for further studies (6). Nevertheless, the same study also reported that the mutant OmpT has 
70% of wild type activity using one type of activity assay, but only about 1% using the other 
assay (1). This information was a piece of compelling evidence later for me to decide abandon 
G216K/K217G mutant efforts. In addition to point mutation, another engineered OmpT variant 
also cloned and tested, which has an altered substrate specificity (cleaves between Glu-Ala, 
named EA-OmpT in this thesis), and doesn't have a Glu-Ala site within its sequence, thus saving 
the self-degradation issue hopefully (7). Another closely related omptin family member, OmpP 
was also tested as an possible alternative (8, 9). Moreover, various other possible options to 
prevent OmpT autolysis were also tested, including chemical modification (i.e. reductive 
methylation, as on trypsin(10)) of the degradation site, divalent cation inhibition (3, 4, 11, 12) 
and such efforts will be discussed further in Results. 
Another essential aspect of OmpT is that it requires the binding of LPS for its enzymatic 
activity (1, 13, 14). Although the exact mechanism for LPS to activate OmpT is not clear yet, it 
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is thought that upon binding to LPS, the amino acids at the active site undergo some subtle but 
important conformational changes, which presumably activate OmpT (14). This requirement 
may serve as a safe-proof mechanism to protect the E.coli itself in vivo, because if the newly 
synthesized OmpT becomes active immediately after translation prior to its transportation to the 
outer membrane, unwanted proteolysis might occur within E.coli cytoplasm, causing OmpT 
cytotoxicity. LPS is only present in the E.coli outer membrane; hence, OmpT will only become 
activated when it gets liganded to LPS after transported to its outer membrane destination. In this 
way, undesired proteolysis within E.coli could be minimized. The LPS binding sites are 
predicted to locate on one side of the beta-barrel, and after liganding to OmpT, the top part of 
LPS is spatially close to loops on top of the beta-barrel (2). This might provide some useful hints 
of my observation on LPS's effects on OmpT autoproteolysis (discussed below). 
The second part of this chapter is about the optimization work of OmpT digestion 
conditions using four standard proteins. Although optimal digestion conditions have been 
examined before using short peptides, no one has systematically studies how efficiently OmpT 
works on intact proteins and what the optimal conditions are. It was reported that OmpT showed 
proteolytic activity within a pH range from 4.0 - 9.0, depending on the substrates assayed for 
activity (1, 3, 4, 12). Multiple detergents were used during such activity assay as long as the 
detergent concentration is above critical micelle concentration (CMC) (4), indicating OmpT is 
active in various micelle systems. Temperature was not particularly investigated, 37°C being the 
most frequently used one. Substrate concentration also varies with the type of molecules for the 
activity assay. Finally, the type and concentration of denaturant, whose presence may prove to be 
critical to OmpT digestion efficiency, has not been studied carefully before. All these parameters 
will be interrogated in this chapter. 
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After the digestion conditions were optimized using standard proteins, LC-MS/MS 
analysis of the digested peptide products was performed. The observation of the OmpT cleavage 
sites according to identified OmpT peptide products gave us further clues to understand the exact 
substrate specificity, especially under denaturing conditions, when large intact proteins were 
used as its substrates. 
 
2.2 - Experimental procedures 
Reagents. DNA restriction enzymes were purchased from Invitrogen and T4 DNA ligase 
was purchased from New England Biolabs. The pET28a vector and E. coli BL21(DE3) cells 
were obtained from EMD Biosciences. The SP-Sepharose media and the K16/20 cation 
exchange column were bought from GE Healthcare Life Sciences. Isopropyl-β-D-
thiogalactopyranoside (IPTG) was from Roche; the LPS was extracted from E.coli strain 
0111:B4 (catalog number: L2630, purchased from Sigma-Aldrich); all other chemicals were 
purchased from either Thermo Fisher Scientific or Sigma-Aldrich unless otherwise noted. The 
fluorogenic substrate Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 (Abz, o-aminobenzoyl; Tyr(NO2), 3-
nitrotyrosine) was synthesized by the Protein Sciences Facility at the University of Illinois by 
Professor Peter Yau and Dr. Brian Imai (1). 
Cloning of expression plasmids containing the genes of the wild type OmpT, 
G216K/K217G OmpT mutant ,EA-OmpT or OmpP. All PCR used Phusion Hot Start 
Polymerase (Finnzymes) and PCR-grade dNTPs (Invitrogen). PCR products and restriction-
digested DNA were purified with the Qiaquick gel extraction and PCR cleanup kits (Qiagen).  
Wild type OmpT - The OmpT gene was amplified from the genomic DNA of E. coli K12 
DH5α (extracted using Qiagen genome DNA extraction kit). The primer sequences used for 
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cloning wild type OmpT were 5'-ATGCGGGCGAAACTTCTGGGAATAG-3' (forward-1) and 
5'-TTAAAATGTGTACTTAAGACCAGCAGTAGTG-3' (reverse-1) from IDT. After the full-
length OmpT gene was cloned, another pair of primers containing restriction sites was used to 
amplify the gene without the N-terminal signal peptide with the sequences 5'-
ATTAATCCATGGCTTCTCGAGACTTTATCGTTTA-3' (forward-2) and 5'-
ACTCGGGAATTCTTAAAAGTGTACTTAAGACCAG-3' (reverse-2). The amplified OmpT 
gene contains an NcoI restriction site at the 5' end and an EcoRI site at the 3' end (underlined). 
Both the pET28a vector and OmpT were doubly digested with NcoI and EcoRI (Invitrogen) and 
ligated to produce pNK1009, which was used to transform E. coli BL21(DE3) for protein 
expression after sequence confirmation by the University of Illinois Core DNA Sequencing 
Facility. 
G216K/K217G mutant OmpT - The G216K/K217G mutant OmpT gene sequence was 
obtained through mega PCR mutagenesis. A pair of primers with mutated DNA bases pairs 
corresponding to the two altered amino acid sequence at 216 and 217 was designed with 
sequences 5'- CACTATGACCCGAAAGGAAGAATCACTTATCGC -3' (use together with the 
forward-2 primer above to amplify the first half of OmpT gene from the 5'-end to the mutated 
region) and 5'- GCGATAAGTGATTCTTCCTTTCGGGTCATAGTG-3' (use together with the 
reverse-2 primer above to amplify the second half of OmpT gene from the mutated region to the 
3'-end). In mega PCR, the first half of the OmpT gene was amplified first, then the purified 
products were directly used as a "mega" primer to pair up with the reverse-2 primer mentioned 
above, to amplify the whole OmpT gene. The traditional mutagenesis didn't work in which the 
two halves were amplified separately and mixed together for annealing and full length 
elongation. One can also do the other way around, where the second half of the OmpT gene was 
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amplified first, then the purified products were directly used as a "mega" primer to pair up with 
the forward-2 primer mentioned above, to amplify the whole OmpT gene, which was not used in 
this work. The resultant G216K/K217G mutant OmpT gene was cloned into pET28a vector for 
protein expression. 
EA-OmpT and OmpP - The EA-OmpT gene was synthesized by GenScript, with 10 
mutated amino acids in the sequence (7). The OmpP gene was cloned from the plasmid pCM131 
obtained from Professor Koreaki Ito from Kyoto University as a generous gift (9). Both genes 
were cloned into pET28a vector for protein expression. For the construction of EA-OmpT 
expression vector, the same set of primers were used as the wild type gene cloning, as the 
starting and ending sequences of both OmpT genes were the same. Again, EA-OmpT without the 
signal peptide was cloned into the expression vector for inclusion body expression, as the wild 
type. For the construction of OmpP expression vector, the sequences of the primer pair were 5’- 
TATATCATGAACACTAAGCTTCTGGCAATTATGCT-3’ (forward) and 5'- 
ACTCGGGAATTCTTAAAACGTGTACTTCAGACCGG-3' (reverse). The amplified OmpP 
gene contained an BspHI restriction site at the 5' end and an EcoRI site at the 3' end (underlined) 
for double digestion and insertion into the vector. 
Protease expression and purification. Both wild type OmpT and OmpT variants 
(G216K/K217G, EA-OmpT) were expressed in inclusion bodies in BL21(DE3) as previously 
described with some modifications (1). Briefly, BL21(DE3) cells containing pNK1009 were 
grown overnight in 5 ml S.O.C. medium (20 g Bacto-Tryptone, 5 g Bacto Yeast Extract, 0.5 g 
NaCl, 2.5 ml of 1 M KCl, 20 ml of 1 M glucose in 1 liter H2O) with 50 mg/l kanamycin at 37C. 
The 5 ml starter culture was inoculated into 1 liter S.O.C medium with 50 mg/L kanamycin and 
grown to an OD600 between 1.0 and 1.5. The expression of OmpT inclusion bodies was induced 
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by the addition of 1 M IPTG to a final concentration of 0.4 mM, followed by further incubation 
at 37C for 6–9 h. 
First, inclusion bodies were isolated from the cell pellet as described before with some 
modifications(15). Briefly, the cell pellet from a 1 liter culture was resuspended in 12 ml lysis 
buffer (50 mM Tris-HCl, 40 mM EDTA, pH 8.0) and incubated with 3 mg lysozyme on ice for 
30 min, and another 12 ml pre-chilled lysis buffer was added quickly to introduce osmotic shock, 
followed by incubation on ice for another 30 min. The lysate was sonicated at 25 watts with a 
Sonic Dismembrator (Model 100, Fisher Scientific) every other minute for five times until the 
lysate was no longer viscous. Inclusion bodies were collected by centrifugation at 4,500 × g for 
30 min. The resultant pellet containing OmpT inclusion bodies was then washed once with 30 ml 
of wash buffer (10 mM Tris-HCl, 1mM EDTA, pH 8.0). 
To extract the resolubilize OmpT inclusion bodies, 4 ml of dissolving buffer (8 M urea, 
50 mM glycine, pH 8.3) were added to the pellet and was pump up and down several times with 
pipette to stir up the pellet for better mixing. Then the mixture was incubated on ice for 30 min. 
Depending on the protein expression level in different E.coli batches, the dissolving buffer 
volume may vary. It is optimal to make the OmpT concentration in refolding solution at around 
0.3 mg/mL after the addition of N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate 
(DodMe2NPrSO3). To refold the solubilized OmpT into its active form, 16 ml of pre-chilled 
31.25 mM DodMe2NPrSO3 was added to the solution. Shake the mixture gently and briefly 
before adjusting the pH of the refolding mixture to 4.0 using 10% acetic acid. Some protein 
precipitation may be observable at this step, but OmpT should stay in solution. Then the solution 
was centrifuged at 20,450 × g, filtered with 0.45 um filter prior to further cation exchange 
purification. 
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A 10 ml Fast Flow SP-Sepharose column (16 mm in diameter, 5 cm in length) was used 
for cation exchange purification. The column was first equilibrated with buffer A (10 mM 
DodMe2NPrSO3, 20 mM sodium acetate, pH 4.0); then 10 ml of the centrifuged and filtered 
supernatant containing refolded OmpT was loaded onto the column and washed with 5 column 
volumes of buffer A. A linear gradient of NaCl to 1 M in 300 ml of buffer A was used to elute 
off proteins. Based on the FPLC chromatogram and SDS-PAGE analysis, fractions containing 
OmpT were pooled, aliquoted and LPS was added (1, 2) to a final concentration of 0.1 mM 
before frozen at –80°C for storage. The OmpT activity was confirmed using the synthetic 
fluorogenic substrate Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 (1). 
Since no one has used the inclusion body method to express and purify OmpP, a 
previously used approach was followed for OmpP purification via DEAE anion exchange 
column, which is not elaborated on here (8). 
Standard protein digestions. Standard proteins carbonic anhydrase (bovine, 29 kDa), 
GAPDH (rabbit, 36 kDa) and phosphorylase b (rabbit, 97 kDa) were directly dissolved in 8 M 
urea to make 2–5 mg/ml stock solutions. Bovine serum albumin (BSA, 69 kDa) was reduced in 5 
mM dithiothreitol (DTT), alkylated with 10 mM iodoacetamide in the dark and precipitated with 
ice-cold acetone before resuspension in 8 M urea for OmpT digestion. To obtain active enzyme, 
aliquoted and frozen OmpT solution after cation exchange was thawed on ice, activated with 0.1 
mM LPS overnight(1, 2, 14) and dialyzed against enzymatic buffer (10 mM DodMe2NPrSO3, 10 
mM Bis-Tris-HCl, 2 mM EDTA, pH 6.0) to remove high concentration salt and to bring the 
solution to a desired pH. Immediately after dialysis, OmpT (liganded to LPS) was mixed with 8-
M-urea resuspended standard proteins at a substrate:enzyme ratio of up to 75:1, to make a final 
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protein concentration at 0.3–0.75 mg/ml. The digestion mixture was incubated at either 22°C or 
37°C overnight before SDS-PAGE coomassie staining or MS assays. 
Nanocapillary liquid chromatography-mass spectrometry (nanoLC-MS/MS). The 
digested samples were cleaned up via methanol-chloroform precipitation to remove the detergent 
DodMe2NPrSO3 prior to nanoLC-MS/MS analysis. A PLRP-S trap column (New Objective, 
Inc.), 150 μm inner diameter (i.d.) with a 3 cm media length, was used for sample loading, 
followed by a 10 cm long × 75 μm i.d. PLRP-S analytical column for sample separation. A linear 
gradient flowing at 300 nL/min from an Eksigent 2D system started from 95% buffer A and 5% 
buffer B (5% H2O, 95% acetonitrile, 0.2% formic acid), ramped to 40% B in 55 min, and finally 
85% B in 15 min. Samples eluted from the nanoLC were electrosprayed into a custom hybrid 
linear ion trap Fourier transform ion cyclotron resonance mass spectrometer (11 Tesla LTQ-FT-
Ultra mass spectrometer, Thermo Fisher Scientific). Samples were analyzed using a data-
dependent top 2 or top 3 method. Collision-induced dissociation (CID) was applied with a 10–15 
m/z isolation window and normalized collision energy of 41%; for MS1, 1–6 microscans at 
160,000 resolving power at 400 m/z were used with a target value of 1 million and scan range of 
m/z 450–1,800 in the Fourier transform ion cyclotron resonance cell (FT-ICR); for MS2, 2–6 
microscans at 80,000 resolving power were used with a target value of 1–1.5 million in the FT-
ICR. 
Data reduction and database searching. Each LC-MS/MS run was collected as a .raw 
file and processed with ProSightPC 2.0 SP1 software (Thermo Fisher Scientific) (16). Briefly, 
monoisotopic neutral precursor and fragment masses were determined using the Xtract algorithm 
(Thermo Fisher Scientific), complied into a .puf file (ProSight Upload Format) and searched on a 
local computer using biomarker search mode against custom-built single protein database, which 
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only contains one standard protein sequence corresponding to the digested protein substrate. 
Biomarker search mode does not assume any hypothetical cleavages in the database and queries 
every possible sub-sequence of any protein in the intact standard protein database for a match 
within the defined mass tolerance window. In this mode, the precursor mass tolerance window 
was set to 1.1 Da and the fragment mass tolerance was set to 10 ppm. Biomarker hits were 
evaluated using a scoring algorithm published previously (raw p score) (17). 
 
2.3 - Results 
2.3.1 - Establishment of OmpT overexpression and purification system 
Inclusion body expression strategy was adopted in this study because of the reasons 
mentioned in Introduction. The induction and expression of OmpT inclusion bodies was 
successful based on gel assays and upon centrifugation, inclusion bodies predominantly go to 
cell pellet (Figure 2.1a, lane 5). The overall yield of OmpT protein was ~10 - 20 mg per liter 
culture. The purity of extracted OmpT inclusion bodies in refolding system is moderately high 
with only one abundant co-purified protein (Figure 2.1c, lane R), which was separated 
effectively via cation exchange (Figure 2.1b-d). To confirm the purified OmpT was indeed 
active, I used a tetrapeptide, Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2, with an N-terminal 
fluorophore and a C-terminal quencher (1), and upon OmpT cleavage between Arg-Arg, the N-
terminal fluorophore becomes free and fluorescent with a maximum emission length at 430 nm 
with excitation wavelength of 325 nm. I used 1 ml solution of the tetrapeptide substrate and 
spiked only 5 ul OmpT after cation exchange into the substrate solution, so that the effect of high 
concentration salt and low pH from the cation exchange was negligible after mixing with the 
substrate solution. Using this assay, I confirmed OmpT's proteolytic activity (Figure 2.2e). 
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2.3.2 - Attempts to overcome OmpT auto-degradation issue and the effect of LPS 
As OmpT was in a solution with high concentration sodium chloride and low pH after 
cation exchange, its activity was compromised because positively charged ions, especially 
divalent cations, behave as OmpT inhibitor (3, 4, 11, 12). Although sodium is singly charged, 
high concentration (~0.8 M as in the OmpT solution) may inhibit OmpT's activity as well. Also, 
pH 4.0 may not be the optimal condition either according to some literature while other reports 
did use pH 4.0 for OmpT digestion. It seems like a dialysis step was desired to bring it to optimal 
working conditions. Therefore, two liters of 10 mM DodMe2NPrSO3 and 10 mM Bis-Tris-HCl at 
pH 6.5 was used as the initial dialysis buffer. OmpT after cation exchange was dialyzed against it 
for four hours at 4°C. 
Unfortunately, although the majority of OmpT was still intact right after cation exchange 
(Figure 2.2a, lane 1), it mostly got degraded quickly during dialysis (even after only 30 min., 
data not shown) and only a small amount of OmpT remained intact after four hours dialysis 
(Figure 2.2a, lane 2). Impressively, even with that small amount of active form left, OmpT after 
dialysis was still able to deplete standard protein GAPDH and digest it into peptides (data not 
shown). I also tried digesting proteome samples using this largely degraded enzyme, but the 
digestion looked incomplete and inefficient (data not shown). So further actions were needed to 
minimize OmpT suicide and stabilize the protease for robust digestion. 
A great amount of efforts were poured into the search for a freasible way to slow down 
the degradation or stabilize the protease. An OmpT variant with ~100-fold higher activity was 
found using directed evolution method, which cleaves between Glu and Ala and does not contain 
a Glu-Ala site within this variant sequence. So the gene of this OmpT variant was synthesize and 
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cloned. The variant protein was expressed, purified and dialyzed using the same workflow as the 
wild type OmpT, but showed no observable activity using standard protein digestion. Another 
omptin family member, OmpP, which shares >70% sequence identity to OmpT, was also cloned 
and purified using anion exchange. Its activity was confirmed using GAPDH digestion, but its 
efficiency was even lower than the largely digested OmpT (data not shown). The G216K/K217G 
mutant was also cloned and purified for activity test. However, while this protease did not show 
self-degradation to any noticeable extent, SDS-PAGE gel assay showed that it didn't cleave the 
substrate GAPDH either. Another idea was to inhibit OmpT's activity during purification using 
divalent cations, such as Zn
2+
 or Cu
2+
, and remove it from the system by adding EDTA. I tried 
both Zn
2+
 and Cu
2+
 inhibition and it worked well to prevent OmpT self-degradation; however, it 
was very difficult to remove such cations completely using EDTA, so the activity of OmpT was 
not recovered after several possible means had been tested (data not shown). I also explored the 
possibility of reductive methylation on the lysine side chain, to slow down the self-degradation at 
this site, assuming it works equally well as on trypsin (10). Nevertheless, the reagent involved in 
reductive methylation (also needs copper) was not compatible with OmpT digestion conditions, 
causing me to give up this option after brief trials.  
When I almost exhausted all possible ways to prevent OmpT self-degradation and 
thought this project went into a dead end since I could never get a stably active enzyme, one 
subtle observation brought my attention. Even if almost all OmpT was degraded after dialysis, 
there was always a small portion that stay intact and active, and it was actually such amount that 
was able to deplete several micrograms of GAPDH substrate. At the same time, I assumed that 
all OmpT was liganded to LPS already in the refolding system, despite the fact that I didn't 
supplement additional LPS in the refolding solution, because membrane debris also went to the 
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pellet along with OmpT inclusion bodies and presumably contained LPS to bind to OmpT. But 
the observation that a small portion of OmpT stayed resistant to self-degradation led me to think 
that the OmpT population in the refolding solution might be heterogeneous. In other words, I 
suspect that maybe only that small amount of OmpT indeed liganded with LPS and the majority 
didn't due to the limited amount of LPS from in vivo. And it was the same portion of the OmpT 
liganded to LPS that was resistant to self-degradation and responsible for the degradation of rest 
that was not liganded to LPS. To test my hypothesis that LPS can stabilize OmpT (in addition to 
the fact that it is required to activate OmpT), assuming there wasn't enough endogenous LPS for 
OmpT to ligand with, I added LPS to the OmpT solution after cation exchange to a final 
concentration of 0.1-0.2 mM, and then performed dialysis. Intriguingly and excitingly, the 
majority of OmpT did stay intact and resistant to self-degradation after dialysis (Figure 2.2a, 
lane 3). 
The effect of LPS on the stabilization of OmpT was significant. I assayed LPS-bound 
OmpT after sitting at 22°C for a month for the extent of degradation and its activity, about half 
of OmpT remained in intact form and protein substrates were completely digested and (data not 
shown), meaning the self-degradation still existed but was slowed down dramatically. Up to 
now, a robust pipeline to yield stable OmpT reagent has been established (Figure 2.2b). 
 
2.3.3 - Optimization of OmpT digestion conditions using four standard proteins 
Since no literature has reported detailed optimization work to maximize OmpT's activity 
to digest intact proteins, several digestion conditions were optimized using four standard 
proteins, carbonic anhydrase (29 kDa), GAPDH (36 kDa), BSA (69 kDa) and Phosphorylase b 
(97 kDa). First, I evaluated the effects of different pH on OmpT digestion efficiency (Figure 
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2.3a-e). Among the four pH conditions used, 5.6, 6.0, 6.5 and 7.0, OmpT showed maximum 
efficiency at pH 5.6 and 6.0. Although pH 5.6 seemed to work slightly better than 6.0, 6.0 was 
chosen for future digestions, because it was closer to neutral pH, thus would introduce less 
digestion bias due to extreme pH condition. One thing that should be noted is that this part was 
done before the LPS stabilization effect was figured out, so the OmpT used suffered severe auto-
cleavage and the activity was compromised (as shown by black arrow in Figure 2.3a,b). 
As discussed previously, denaturant is required to expose OmpT cleavage sites within 
protein substrates for efficient digestion. After several detergents were tested, including SDS, 
guanidine hydrochloride and urea, urea turned out to work best (data not shown). Because urea 
reacts with lysine side chains to form carbamylation adducts and interfere with downstream MS 
analysis, two incubation temperatures were examined and 22°C incubation worked better for 
both better digestion efficiency (Figure 2.3f) and minimized carbamylated adducts based on MS 
analysis (data not shown). 
Optimal urea concentration was then investigated. In this case, I needed to maintain a 
subtle balance between the extent of substrate denaturation and the negative effect of urea on 
OmpT's activity, by selecting the right urea concentration. According to the standard protein 
digestions, 3.2 M urea is the best fit to all digestions, although a couple of urea concentrations 
work for some substrates (Figure 2.3g-j). 
Different substrate concentrations as well as OmpT concentrations were also tested (data 
not shown). A wide range of substrate concentration could be used in OmpT digestion, from 0.1 
mg/mL up to ~1 mg/mL. OmpT concentration fell in the order of hundreds of nanomolar. The 
substrate-to-enzyme ratio varied but could be up to 100:1 by mass ratio. 
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2.3.4 - Characterization of standard protein digestions using nanoLC-MS/MS 
After the optimization of digestion conditions, all the digested peptide products from 
standard protein digestions were analyzed by nanoLC-MS/MS. Because of the presence of 
DodMe2NPrSO3 in the digestion system, samples after digestion were cleaned up first through 
methanol-chloroform precipitation to remove this detergent. As an example, peptide products 
from GAPDH after digestion by OmpT were visualized on a Coomassie stained SDS-PAGE gel 
(Figure 2.4a), characterized via nanoLC-MS/MS (Figure 2.4b-d) and identified by ProSightPC, 
with their cleavage sites highlighted in the peptide map aligned with the original GAPDH 
sequence (Figure 2.4e). Interestingly, in addition to predicted dibasic cleavages, I observed a K-
A cleavage. I also detected this K-A missed cleavage product both on the gel (Figure 2.4a, 
peptide 4) and by LC-MS/MS (Figure 2.4e, peptide 4). Although there is a K-K site within the 
GAPDH sequence, the cleaved product at this site (peptide 5 in Figure 2.4e) was barely 
observable in the LC-MS/MS run (data not shown). There are also some non-dibasic cleavages 
in phosphorylase b sequence. Substrate specificity will be discussed in great detail below. 
The other three standard protein digestions were also visualized on Coomassie stained 
gels (Figure 2.3g, i and j). The identified peptides from carbonic anhydrase, GAPDH and 
phosphorylase b were illustrated along with their cleavage sites highlighted in the protein 
sequences (Note 2.1a-c). We obtained 100% sequence coverage for both GAPDH and carbonic 
anhydrase and 84% coverage for phosphorylase b via identified peptides. Although peptides 
from BSA after OmpT cleavages were readily seen on Coomassie stained gels (Figure 2.3i), no 
peptides were confidently identified, mostly likely due to their still-large sizes. 
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2.4 - Discussion 
Thanks to extensive previous literature knowledge, the overexpression and purification of 
wild type OmpT was readily established. I would like to point out just one potential concern for 
OmpT protein expression. Although it was rare, but I did notice that if BL21(DE1) cells that had 
been transformed with OmpT expression plasmid were stored only at 4°C solid agar plate for a 
long time, they might be possible to lose the plasmid. This might be due to the leaky expression 
of pNK1009 (Figure 2.1a, lane 3), which could lead to a small amount of soluble and active 
OmpT to express causing cytotoxicity (Figure 2.1a, lane 4), and this may apply a selection force 
to the colonies that tended to lose OmpT-containing plasmids, pNK1009. Therefore, to make sure 
that OmpT can be expressed in large quantity successfully, transforming new BL21(DE1) cells 
with OmpT-containing plasmids every time. 
Even though it seemed like that EA-OmpT and OmpP didn't seem to work as an 
alternative option to wild type OmpT, there are several caveats to keep in mind. For EA-OmpT, 
no one has used the inclusion body strategy to express and purify it as I did; so this might not 
yield active enzyme in the first place. In order to evaluate the feasibility of EA-OmpT for robust 
and restricted protelysis in a definitive way, EA-OmpT should be purified from outer membrane 
as described before (7) for activity test. Furthermore, since there are ten amino acid mutations in 
EA-OmpT sequence, the protein chemistry might alter significantly. But I adopted the same 
digestion conditions as wild type OmpT to EA-OmpT test. So the digestion system may not be 
optimal for EA-OmpT's activity. The same argument also applies to OmpP test. In summary, 
further efforts are inevitably required to determine the applicability of EA-OmpT and OmpP for 
restricted proteolysis conclusively. 
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One possible reason why LPS could stabilize OmpT might be that the top part of LPS is 
close to loops (Lys217-Arg218 are on loop 4) on top of OmpT, which may provide spatial 
hindrance to access this region (2). It is also noteworthy that not only LPS played a critical role 
in stabilizing OmpT, but also the high concentration sodium chloride in the cation exchange 
buffer, in which OmpT was eluted, was also highly desired. The reason is that there need to be 
another reversible inhibitor than LPS to slow down OmpT degradation, before LPS was added to 
stabilize OmpT, namely from OmpT refolding step to OmpT's elution off the cation exchange 
column. And sodium used for gradient elution in cation exchange happened to serve this purpose 
ideally. But as mentioned before, for singly charged cations, such as sodium, the inhibitory effect 
may not be as substantial as divalent cations. Thus, a higher concentration might provide more 
inhibition. This was why I chose a slight different cation exchange media from the previous 
protocol, which had stronger binding affinity to OmpT, making a higher sodium chloride 
concentration required for OmpT elution, so that the activity inhibition by sodium was enhanced 
and the degradation was slowed down. 
Despite the quite effective stabilization of OmpT by LPS, it seemed like that there was 
always a small portion of OmpT that inevitably underwent auto-proteolysis (e.g. Figure 2.3f, 
lane E2). I think two major factors might have contributed to this observation. First, because of 
the presence of in vivo LPS in the inclusion body pellet, OmpT could start cleaving itself 
immediately after refolding. Indeed, I left the refolding solution long enough, and analyzed the 
extent of OmpT self-degradation by SDS-PAGE. It can be dramatic, with the majority of the 
enzyme degraded, depending on the length of the time it was left prior to the assay (data not 
shown). Second, the OmpT solutions would experience one freeze-and-thaw step at least after 
the cation exchange purification before dialysis for actual digestion, which might also introduce 
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self-degradation, although high salt was present. The degraded OmpT product (the smaller piece) 
indeed became a major interfering species for downstream MS analysis. 
Another interesting phenomenon was that while the addition of LPS significantly slowed 
down OmpT autocleavage, it also seemed to change the OmpT substrate preference very subtly, 
if any. Based on the comparison of generated OmpT peptides from standard protein digestions, 
the intensities of some of the bands altered delicately, depending on if the OmpT used for 
digestion contained additional LPS (Figure 2.5). Also, the residual undigested phosphorylase b 
became even more in the digestion using OmpT with LPS, even if there was more active OmpT 
in this case. This might be another piece of side evidence that the LPS somewhat changes the 
OmpT's substrate preference (but not specificity), making it more difficult to digest some of the 
sites (possibly the ones close to the N- or C-terminal of phosphorylase b, for 3.2 M urea couldn't 
completely linearize this large substrate and the first several cleavages may become essential to 
deplete the substrate and to make sure the following cleavages occur at all). One potential reason 
for this marginally altered substrate preference may derive from the structural difference (14) 
between the LPS in vivo (from BL21(DE3) outer membrane and liganded to OmpT upon 
refolding) and the commercial LPS purchased from vender, although no solid structural 
information was available for confirmation. 
Finally, a Lys-Ala cleavage in GAPDH digestion and a Arg-Val cleavage in 
phosphorylase b digestion were observed (Note 2.1b and c), which corroborated previous reports 
that OmpT can still cleave with other aliphatic amino acid residues in its P1' position (6, 18), 
especially under extreme denaturing conditions (19). A Lys-Lys missed cleavage was also 
observed in GAPDH digestion (Note 2.1b). This is likely because the flanking amino acid 
residues in the P2 and P3 positions are both aspartic acid residues; these negative charges may 
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prevent the binding of the nearby K-K site to the negatively charged active site of OmpT (2). 
Such already observed cleavage sites based on standard protein digestion suggests that dibasic 
sites may not be the most accurate way to describe OmpT's substrate specificity, at lease under 
the optimized conditions in this study. The substrate specificity topic is a main focus in Chapter 
III, after proteomic data is introduced and statistical analysis is performed. 
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2.5 - Figures and Notes 
 
Figure 2.1: Overexpression of OmpT in the form of inclusion bodies, cation exchange 
results and tetrapeptide assay. (a) Overexpression of OmpT. Lane 1, supernatant of E.coli 
BL21(DE3) lysate before IPTG induction; lane 2,  pellet of cell lysate before induction; lane 3, 
whole cell lysate before induction; lane 4, supernatant of cell lysate after IPTG induction; lane 5, 
pellet of cell lysate after induction; lane 6, whole cell lysate after induction. Black arrow denotes 
OmpT. (b) A typical FPLC chromatogram of cation exchange purification of OmpT. (c-d) 
Coomassie-stained fractions from FPLC. The numbers on top of each lane corresponds to the 
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Figure 2.1 (cont.) fraction number in (b); lane R indicates OmpT in refolding solution before 
loading onto cation exchange column. (e) In the activity assay, 5 ul of OmpT was directly spiked 
in 1 ml of tetrapeptide solution (1mM Tween 20, 5 mM EDTA, 10mM Bis-tris, 5μM tetrapeptide 
substrate, at pH 6.5) and subjected to fluorescence detection via a fluorimeter (1). 
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Figure 2.2: The effect of LPS on the stability of OmpT and the established pipeline for the 
production of active and stable OmpT. (a) Lane 1 showed that most OmpT right after cation 
exchange purification (several fractions containing OmpT were pooled in this case) still 
remained intact. Lane 2 illustrated that the majority of OmpT was degraded after dialysis against 
enzymatic buffer without the addition of LPS. Lane 3 illustrated that the majority of OmpT 
stayed intact when LPS was added before the same dialysis step as lane 2. Blue arrow indicates 
intact form of OmpT; red arrow marks degraded form of OmpT after autoproteolysis between 
K217-R218. (b) Established pipeline for OmpT expression and purification. After cloning OmpT 
gene without the signal peptide into pET28a vector, the plasmid was transformed into E.coli for 
protein expression in the form of inclusion bodies, which is isolated and purified. LPS is added 
to the fractions containing OmpT to a final concentration of 0.1-0.2 mM. Then OmpT was 
dialyzed against enzymatic buffer for substrate digestion. 
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Figure 2.3: Optimization of OmpT digestion conditions, including pH, incubation 
temperature and urea concentration. (a) All the digestions were analyzed via SDS-PAGE and 
Coomassie staining. Protein ladders were labeled on the left side of each gel. Carbonic anhydrase 
incubated with OmpT at pH ranging from 6.0 to 7.0. Lane C, carbonic anhydrase control 
incubated without OmpT; lane 1-3, carbonic anhydrase incubated with OmpT in 2 M urea at pH 
6.5, 6.0 and 7.0, respectively; lane E, OmpT enzyme control. Note that the intact and active form 
of OmpT was marked by black arrowhead. (b) GAPDH incubated with OmpT at pH ranging 
from 6.0 to 7.0. Lane C, GAPDH control incubated without OmpT; lane 1-3, GAPDH incubated 
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Figure 2.3 (cont.) with OmpT in 2 M urea at pH 6.0, 6.5 and 7.0, respectively; lane 4, replicate 
of lane 3; lane E, OmpT enzyme control. (c-e) Standard proteins, including carbonic anhydrase 
(29 kDa), GAPDH (36 kDa) or BSA (69 kDa), incubated with OmpT respectively, at pH ranging 
from 5.6 to 6.5. Lane C, standard protein controls incubated without OmpT; lane 1-2, standard 
proteins incubated with OmpT at pH 5.6, in 2 M and 2.7 M urea respectively; lane 3-4, standard 
proteins incubated with OmpT at pH 6.0, in 2 M and 2.7 M urea respectively; lane 5-6, standard 
proteins incubated with OmpT at pH 6.5, in 2 M and 2.7 M urea respectively. (f) Comparison 
between 37˚C and 22˚C incubation. GAPDH was digested by OmpT at 37˚C and 22˚C in 
different urea concentrations. Lane C, GAPDH control incubated overnight in the absence of 
OmpT; lane E1, OmpT enzyme control after overnight incubation; E2, freshly prepared OmpT 
enzyme control before overnight incubation; the blue arrowhead indicates intact OmpT enzyme; 
the red arrowhead indicates degraded OmpT enzyme after autocleavage at the site R217-K218; 
urea concentration is 2.0 M in lane 1 and 2, 3.2 M in lane 3 and 4 and 4.0 M in lane 5 and 6. (g-
h) Digestion of standard proteins by OmpT, including carbonic anhydrase, GAPDH, BSA and 
phosphorylase b respectively, in different urea concentrations at 22˚C. M, molecular weight 
ladder; E, OmpT enzyme control after overnight incubation; C, standard protein controls after 
overnight incubation without OmpT; urea concentration is 2.0 M, 2.8 M, 3.2 M and 4 M in lane 
1, 2, 3 and 4 respectively. This figure is partially adopted from the paper "A protease for 'middle-
down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012) with modifications. 
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Figure 2.4: Characterization of OmpT peptides from standard protein GAPDH digestion. 
(a) Peptide products visualized on a Coomassie stained SDS-PAGE gel. Lane 1, GAPDH 
incubated without OmpT in enzymatic buffer overnight as a control. Lane 2, GAPDH after 
OmpT digestion. Major peptide products are numbered from 1 through 3. Arrowhead indicates 
the OmpT enzyme. (b) Major species (peptides 1–3) in base peak chromatogram of the nanoLC-
MS/MS analysis. (c) Intact charge state distributions of peptides 1–3. (d) Tandem mass spectra 
of indicated charge states. The masses of identified peptides and their raw p scores are shown. (e) 
Alignment of identified OmpT peptides with original GAPDH sequence on top. Peptide cleavage 
sites are illustrated and N and C represent the protein N- and C-termini. This figure is adopted 
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Figure 2.4 (cont.) from the paper "A protease for 'middle-down' proteomics", Wu, C., et al. Nat. 
Methods. 9, 822-824 (2012) with modifications. 
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Figure 2.5: Comparisons of two standard protein digestions using OmpT with or without 
the addition of LPS. (a) Digestions were analyzed via SDS-PAGE and Coomassie staining. 
Protein ladders were labeled on the left side of each gel. GAPDH was digested by OmpT that 
was not stabilized by the addition of LPS. Lane C, GAPDH control incubated without OmpT; 
lane 1-3, carbonic anhydrase incubated with OmpT in 2 M, 3.2 M and 4 M urea respectively; 
lane E, OmpT enzyme control without LPS. (b) GAPDH digested by OmpT that was stabilized 
by the addition of LPS. lane E, OmpT enzyme control with LPS. (c) Phosphorylase b digested by 
OmpT that was not stabilized by the addition of LPS. Lane C, phosphorylase b control incubated 
without OmpT; Lane E, OmpT enzyme control without LPS. (d) Phosphorylase b digested by 
OmpT that was stabilized by the addition of LPS. lane E, OmpT enzyme control with LPS. 
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Note 2.1: Covered standard protein sequences by OmpT peptides. 
a: Covered carbonic anhydrase sequences by identified OmpT peptides (in red) and OmpT 
cleavage sites (in bold blue): 
>sp|P00921|CAH2_BOVIN Carbonic anhydrase 2 OS=Bos taurus GN=CA2 PE=1 
SV=3 
SHHWGYGKHNGPEHWHKDFPIANGERQSPVDIDTKAVVQDPALKPLALVYGEATSRR
MVNNGHSFNVEYDDSQDKAVLKDGPLTGTYRLVQFHFHWGSSDDQGSEHTVDRKKYA
AELHLVHWNTKYGDFGTAAQQPDGLAVVGVFLKVGDANPALQKVLDALDSIKTKGKS
TDFPNFDPGSLLPNVLDYWTYPGSLTTPPLLESVTWIVLKEPISVSSQQMLKFRTLN
FNAEGEPELLMLANWRPAQPLKNRQVRGFPK 
 
b: Covered GAPDH sequences by identified OmpT peptides and OmpT cleavage sites: 
 
>sp|P46406|G3P_RABIT Glyceraldehyde-3-phosphate dehydrogenase OS=Oryctolagus 
cuniculus GN=GAPDH PE=1 SV=3 
VKVGVNGFGRIGRLVTRAAFNSGKVDVVAINDPFIDLHYMVYMFQYDSTHGKFHGTV
KAENGKLVINGKAITIFQERDPANIKWGDAGAEYVVESTGVFTTMEKAGAHLKGGAK
RVIISAPSADAPMFVMGVNHEKYDNSLKIVSNASCTTNCLAPLAKVIHDHFGIVEGL
MTTVHAITATQKTVDGPSGKLWRDGRGAAQNIIPASTGAAKAVGKVIPELNGKLTGM
AFRVPTPNVSVVDLTCRLEKAAKYDDIKKVVKQASEGPLKGILGYTEDQVVSCDFNS
ATHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMVHMASKE 
 
c: Covered phosphorylase b sequences by identified OmpT peptides and OmpT cleavage 
sites: 
>sp|P00489|PYGM_RABIT Glycogen phosphorylase, muscle form 
OS=Oryctolagus cuniculus GN=PYGM PE=1 SV=3  
SRPLSDQEKRKQISVRGLAGVENVTELKKNFNRHLHFTLVKDRNVATPRDYYFALAH
TVRDHLVGRWIRTQQHYYEKDPKRIYYLSLEFYMGRTLQNTMVNLALENACDEATYQ
LGLDMEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEFGIFNQKIC
GGWQMEEADDWLRYGNPWEKARPEFTLPVHFYGRVEHTSQGAKWVDTQVVLAMPYDT
PVPGYRNNVVNTMRLWSAKAPNDFNLKDFNVGGYIQAVLDRNLAENISRVLYPNDNF
FEGKELRLKQEYFVVAATLQDIIRRFKSSKFGCRDPVRTNFDAFPDKVAIQLNDTHP
SLAIPELMRVLVDLERLDWDKAWEVTVKTCAYTNHTVLPEALERWPVHLLETLLPRH
LQIIYEINQRFLNRVAAAFPGDVDRLRRMSLVEEGAVKRINMAHLCIAGSHAVNGVA
RIHSEILKKTIFKDFYELEPHKFQNKTNGITPRRWLVLCNPGLAEIIAERIGEEYIS
DLDQLRKLLSYVDDEAFIRDVAKVKQENKLKFAAYLEREYKVHINPNSLFDVQVKRI
HEYKRQLLNCLHVITLYNRIKKEPNKFVVPRTVMIGGKAAPGYHMAKMIIKLITAIG
DVVNHDPVVGDRLRVIFLENYRVSLAEKVIPAADLSEQISTAGTEASGTGNMKFMLN
GALTIGTMDGANVEMAEEAGEENFFIFGMRVEDVDRLDQRGYNAQEYYDRIPELRQI
IEQLSSGFFSPKQPDLFKDIVNMLMHHDRFKVFADYEEYVKCQERVSALYKNPREWT
RMVIRNIATSGKFSSDRTIAQYAREIWGVEPSRQRLPAPDEKIP 
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CHAPTER 3: DEVELOPMENT OF OMPT-BASED "MIDDLE-DOWN" PROTEOMICS 
WORKFLOW TO ANALYZE HIGH-MASS PROTEOME OF HELA CELL 
 
Acknowledgment: Some of the text contents and most of the figures in this chapter were 
adopted from the paper "A protease for 'middle-down' proteomics", Wu, C., et al. Nat. Methods. 
9, 822-824 (2012) with modifications. Dr. Neil Kelleher,  Dr. Jonathan Sweedler and Dr. John 
Tran provided a tremendous amount of ideas, comments, suggestions and discussions. Dr John 
Tran provided significant GELFrEE technical supports. Dr. Leonid Zamdborg, Dr. Paul Thomas. 
Bryan Early created the HeLa OmpT peptide databases and performed the FDR estimation. Dr. 
Mingxi Li, Dr. Dorothy Ahlf and Ken Durbin provided HeLa cells. Ken Durbin helped with the 
sequence logo generations. 
 
3.1 - Introduction 
With the success in obtaining stably active OmpT and using it to efficiently digest 
standard proteins after optimization, I moved on to the analysis of complex proteome samples. 
As mentioned before, OmpT was particularly attractive to a top-down research group in a sense 
that it can convert high-mass proteins that are beyond the scope of top down into low-mass 
region that is readily accessible (1, 2). Therefore, the analysis high-mass proteome from HeLa 
cell by OmpT-based middle-down approach becomes the center of this chapter. This also implies 
that a size-dependent proteome separation technique is required to separate the high-mass 
proteome of interest in this study from the low-mass proteome, where top-down proteomics 
works decently well. 
GELFrEE (gel-eluted liquid fraction entrapment electrophoresis) technique served this 
purpose nicely (3). Indeed, integrating GELFrEE into the top-down pipeline, the sample 
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complexity at intact protein level has been greatly reduced in each GELFrEE fraction and a 
dramatic performance boost was achieved thanks to this advancement in frontend sample 
separation (2). Furthermore, by changing the % T of the SDS-PAGE gel cast in the GELFrEE 
glass tube, this versatile technique offered an optimal resolution at different mass ranges can be 
readily accomplished. Through multiplexing, the sample handling capacity has reached the order 
of hundreds of micrograms up to milligrams (4). Therefore, GELFrEE provided the separation 
capability of a wide range of sample amounts and a commercial multiplex GELFREE device was 
adopted for the preparation of high-mass HeLa proteome, so as to obtain ample proteome 
samples for this middle-down test study.  
To make the fractionated protein samples from GELFrEE compatible with OmpT 
digestion, the collected fractions needed to be cleaned up via methanol-chloroform precipitation 
to remove undesired components, mainly SDS, as the proteins after GELFrEE were dissolved in 
SDS-PAGE running buffer. Then, precipitated protein pellets can be recovered in 8 M urea for 
downstream OmpT digestion. Because of the large dynamic range of a complex proteome, a 
lower substrate-to-enzyme ratio than standard protein digestions may be beneficial to ensuring 
the efficient digestion of low-abundance proteins. 
After OmpT digestion, it is predicable that the generated peptides will distribute across a 
broad mass range (as shown by the in silico digest in Chapter I and Figure 3.1, bottom right 
silver-stained gel). Thus a further separation might be desired to reduce the complexity of the 
produced OmpT peptides. High-resolution GELFrEE (a specific set of parameters in terms of 
casting tube gels and operating the device) was applied to the fractionation of digested samples, 
so that OmpT peptides below ~15 kDa was separated at fine mass resolution, enabling well-
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suited data acquisition settings for OmpT peptides at different mass ranges in the downstream 
LC-MS/MS analysis. 
Another essential part of this chapter is the informatic tools established and used to 
identify OmpT peptides. In peptide-centric proteomics, databases for searching are created by 
cleaving the intact proteins in silico based on the substrate specificities of the enzyme used in the 
sample proteolysis (e.g. tryptic peptide databases assume cleavages after Lys or Arg (5)). 
However, according to the observed cleavages from standard protein digestions, dibasic sites 
might not the most accurate description of OmpT's substrate specificity. So the exact substrate 
sequence preference of OmpT needs to be figured out first, in an unbiased way. Biomarker 
search mode in ProSightPC was able to provide us an insight into the consensus sequence of 
OmpT recognition site, and will be discussed thoroughly below. After the confirmation of 
OmpT's substrate specificity, based on which OmpT peptide databases were built for database 
searching, absolute mass search came into play and will be describe in detail as well.  
 
3.2 - Experimental procedures 
Preparation of high-mass HeLa proteome samples. HeLa S3 cells were obtained from 
the American Type Culture Collection and grown as previously described (1). Cells were lysed 
by boiling in cell lysis buffer (4% SDS, 100 mM Tris-HCl, 10 mM DTT, pH 7.5) for 10 min, 
incubated with 100 mM iodoacetamide for 30 min in the dark, aliquoted and frozen at -80˚C for 
future use. To fractionate the whole proteome into molecular mass bins, a continuous tube-gel 
electrophoresis technology, GELFrEE, was applied for primary separation (4). Specifically, an 
eight-channel, multiplexed commercial continuous tube-gel electrophoresis device (GELFREE 
8100 fractionation system, Protein Discovery Inc.) was used with 8% or 10% gel cartridges 
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(Protein Discovery) to prepare the high-mass HeLa proteome. The HEPES-SDS buffer system, 
pH 7.8, was used as recommended by the vendor. To load samples onto the GELFrEE devices, 
protein concentrations were measured using BCA assay and aliquoted HeLa lysates 
corresponding to 1–2 mg of total protein were thawed on ice, precipitated by cold acetone at -20 
˚C for 30 min and air-dried before resuspension with sample loading buffer, and then heated at 
50 ˚C for the commercial GELFrEE. After sample loading, the commercial GELFrEE device 
was operated as described in the manufacturer's instructions. Each fraction contained 1.2 mL of 
sample volume (150 μL for each channel, samples from eight channels were pooled together for 
the same fraction) and fractions corresponding to the high-mass proteome (20–100 kDa) were 
cleaned up by cold acetone precipitation and air-dried prior to resuspension in 8 M urea for 
OmpT digestion. 
OmpT digestion and secondary high-resolution GELFrEE separation.  To obtain 
active enzyme, aliquoted OmpT solution was thawed on ice, activated with 0.1 mM LPS 
overnight (6, 7) and dialyzed against enzymatic buffer (10 mM DodMe2NPrSO3, 10 mM Bis-
Tris-HCl, 2 mM EDTA, pH 6.0). Immediately after dialysis, OmpT (liganded to LPS) was mixed 
with resuspended standard proteins or high-mass HeLa GELFrEE samples and incubated at 22˚C 
overnight. The substrate-to-enzyme ratio was adjusted to ~25:1 by mass (as opposed to higher 
ratio up to 100:1 in standard digestions), to ensure the complete depletion of substrate proteins 
with a broad dynamic range. Digested standard proteins or GELFrEE samples were cleaned up 
by methanol-chloroform precipitation (1, 8) before solubilizing at 100 ˚C in sample loading 
buffer and were loaded onto a single channel custom high-resolution GELFrEE device for 
secondary separation (3). The buffer system of this custom device was Tris-glycine (25 mM Tris, 
0.2 M glycine, 0.1% SDS). Tube gels with Tris-glycine were cast in 3 cm length at 15% T in this 
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secondary GELFrEE for resolving digested peptides. The custom GELFrEE device was operated 
at 180 V and in total, 16 fractions were collected containing proteins up to 30 kDa over 100 min. 
SDS was removed from collected fractions by methanol-chloroform precipitation (8). The 
resultant protein pellets from either standard protein digestions or GELFrEE digestions by OmpT 
were recovered by buffer A (95% H2O, 5% acetonitrile, 0.2% formic acid) solubilization and 
injected onto a nanoLC coupled to a mass spectrometer for on-line characterization as described 
below. 
NanoLC-MS/MS. The majority of the data were collected using a custom hybrid linear 
ion trap Fourier transform ion cyclotron resonance mass spectrometer (11 Tesla LTQ-FT-Ultra 
mass spectrometer, Thermo Fisher Scientific), and the detailed nanoLC-MS/MS setting were 
described thoroughly in Chapter II. For CID and ETD comparison analysis, a Velos Orbitrap 
Elite system was used. Samples were analyzed either using a data-dependent top 3 or 5 method 
in separate CID or ETD runs, or top 2 or 3 method in alternating CID and ETD runs. Both CID 
and ETD were applied with a 15 m/z isolation window; normalized collision energy for CID was 
set at 41% and reaction time for ETD was 5-25 ms. For MS1, 2–4 microscans at 120,000 
resolving power at 400 m/z were used with a target value of 1 million and scan range of m/z 400–
1500 in orbitrap; for MS2, 3-6 microscans at 60,000 resolving power were used with a target 
value of 1 million in the orbitrap. All the raw data files collected are available at Tranche 
(https://proteomecommons.org/group-data.jsp?i=360). 
Data reduction and database searching. Each LC-MS/MS run was collected as a .raw 
file and processed with ProSightPC 2.0 SP1 software (Thermo Fisher Scientific). First, 
monoisotopic neutral precursor and fragment masses were determined using the Xtract algorithm 
(Thermo Fisher Scientific), and each precursor mass along with its corresponding fragment 
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masses formed an "experiment", the basic unit for database searching. All of the experiments 
from a .raw data file were then complied into a .puf file (ProSight Upload Format) and searched 
on a 168-core cluster in two different search modes (absolute mass and biomarker) against two 
shotgun annotated human proteome databases. 
Biomarker search mode does not assume any hypothetical cleavages in the database and 
queries every possible sub-sequence of any protein in the intact protein database (UniProt release 
2011-10) for a match within the defined mass tolerance window. In this mode, the precursor 
mass tolerance window was set to 1.1 Da and the fragment mass tolerance was set to ±10 ppm. 
In order to estimate the false discovery rate (FDR) in biomarker search mode, a q value 
evaluation approach was applied as previously described (2). A decoy database was built by 
scrambling the protein sequences from the forward intact database (2, 9, 10). All data were 
searched against both the forward and decoy databases separately using identical search 
parameters. All search hits were scored using a Poisson-based model (11) (p score) and a 
posterior probability-based q value was calculated for each hit to estimate the FDR for each 
identification event (12, 13). 
For the absolute mass search, a custom peptide database was constructed using the OmpT 
cleavage propensities (P1=K, R; P1'=K, R, A, S, G, V, I, L) determined by biomarker search hits 
(see sequence logo in Figure 3.5d). Eight missed cleavages were considered in constructing this 
Middle Down database, which contained 20 million peptide forms (including signal peptides, 
alternative splice variants and PTMs). To search data in absolute mass mode, ProSightPC's 
iterative searching was used, with the precursor mass tolerance window set to 2.2 Da and the 
fragment tolerance to ±10 ppm for the first level search; an 81 Da precursor mass tolerance and 
±10 ppm fragment tolerance were used for the second level search. FDR estimation was 
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performed as described above. Both the forward and decoy databases for biomarker and absolute 
mass searches are available online using ProSightPTM 2.0 
(http://prosightptm2.northwestern.edu/). ProSightPC users can also download these databases at 
ftp://prosightftp:gsX1gON@prosightpc.northwestern.edu/ and run both search modes locally. 
For cluster users, these databases are also available for searches and listed on the cluster database 
list (http://prosight-cluster.kelleher.northwestern.edu/multi-upload/databases.html, or marked by 
blue rectangle in Figure 4.2 ). 
Peptide hits with a q value lower than 0.01 (1% FDR cut-off) from both the biomarker 
and absolute mass search modes were reported and used for further analysis in this study. A brief 
comparison was drawn between biomarker hits and absolute mass hits (Figure 3.6a). 
ProteinCenter software (Thermo Fisher Scientific) was used to group peptides and cluster protein 
identifications for unique protein counting (Appendix A). 
 
3.3 - Results 
3.3.1 - Establishment of middle-down platform and analysis of HeLa cell high-mass 
proteome 
An OmpT-based platform for Middle Down proteomic analysis was established to 
analyze complex proteome samples (Fig. 3.1). Specifically, the HeLa proteome sample was 
separated by multiplexed primary continuous tube-gel electrophoresis into fractions containing a 
distribution of protein sizes with the best resolution from 20 to 100 kDa. The fractionated 
samples in this mass region were precipitated with cold acetone, resuspended in 8 M urea, and 
digested with OmpT at a ratio of 25:1 (final protein concentration of ~0.5 mg/mL and 3.2 M 
urea). Digested samples underwent a secondary GELFrEE separation and methanol-chloroform 
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precipitation prior to injection on nanoLC-MS/MS. To verify that the precipitated samples can be 
recovered at high rate in 8 M urea, a high-mass fraction was split into two identical fractions and 
precipitated in parallel, and then one was resuspended in 1× SDS-PAGE sample loading buffer 
and the other resuspended in 8 M urea. Based on silver stain assay, there wasn't noticeable 
sample loss using 8 M urea resuspension (data not shown). 
As a representative example using the middle-down pipeline (Fig. 3.2), 109 unique 
peptides with an average length of 6.4 kDa were identified from 67 unique proteins in a single 
run. From the entire Middle Down analysis on the high-mass HeLa proteome (20─100 kDa), I 
identified 3697 unique peptides (average size: 6.3 kDa) from 1038 unique proteins (26% average 
sequence coverage) at an estimated 1% false discovery rate (FDR) (2) (Appendix A). Among 
these peptides, 2493 were confidently identified with an intact peptide tolerance <10 ppm 
without manual verification; peptides with intact mass discrepancies outside this window were 
identified with multiple matching fragment ions <10 ppm but were not further pursued in this 
study. To eliminate the possibility that observed peptides may have come from sample auto-
proteolysis during sample manipulation and not from OmpT digestion, we performed a negative 
control experiment in which all conditions were identical except the addition of OmpT. This 
control experiment led to very few confident identifications (data not shown), indicating that the 
observed peptides were almost exclusively due to OmpT digestion of substrate proteins. 
To profile the mass distribution of identified OmpT peptides, we plotted peptide mass 
frequencies in 1 kDa mass bins up to 14 kDa in comparison with tryptic peptides (Figure 3.3a). 
We only analyzed fractions below ~15 kDa due to its ease of characterization. Although the 
average size of identified OmpT peptides is 6.3 kDa, we estimate that the actual average peptide 
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size based on silver-stained gels is higher than 6.3 kDa (as many peptides above 10 kDa are 
readily visible on gels, see Figure 3.1 bottom right and Figure 3.2c). 
The overlapped and unique hits from absolute mass and biomarker searches at 1% FDR 
were illustrated in a Venn diagram (Figure 3.3b). Because a 1.1 Da precursor tolerance 
window was used in biomarker search mode, only peptides hits with mass differences smaller 
than 1.1 Da in absolute mass search were used for this comparison. The database in absolute 
mass search includes known PTMs, while the database biomarker search used is a simple intact 
protein database without any PTMs. Therefore peptides with known modifications were only 
identified in the absolute mass search mode as shown in the diagram. This comparison 
demonstrated that both biomarker and absolute mass searches are desired in order to obtain an 
inclusive list of peptide identifications, while absolute mass search was more robust and allowed 
PTM characterizations and error-tolerant searching. 
 
3.3.2 - Comparison between CID and ETD 
A brief performance comparison between collision induced dissociation (CID) and 
electron transfer dissociation (ETD) was made using OmpT peptides from three fractions of 
secondary continuous tube-gel electrophoresis. Technical replicates were analyzed in a single run 
with alternating CID and ETD on the same precursors, or in separate runs where only one 
fragmentation technique was used (Appendix B). While the former led to a 48% overlap in 
peptide identifications, ETD vs. CID in separate runs only gave a 23% overlap (Figure 3.3c and 
d). These results suggest that ETD and CID will both serve as effective and highly 
complementary fragmentation approaches to identify and characterize OmpT peptides. 
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3.3.3 - Examples of proteotypic OmpT peptides  
Isoform specific peptide identifications are often elusive in proteomics experiments. We 
were able to differentiate specific protein isoforms based on proteotypic OmpT peptides. 
Detailed sequence alignments between protein isoforms revealed areas of sequence identity, 
while OmpT peptides, owing to their desirably large size, covered those unique regions where 
isoform sequences differed (Figure 3.4). 
Longer peptides can also prove beneficial for detection and identification of modified 
peptides. In this study, ~25% of OmpT peptides were identified with PTMs (using annotated 
modifications from the UniProt database) (1, 2) and several examples of multiply modified 
peptides were found (Fig. 3.5). An additional 8% of unique peptides with unexpected mass 
discrepancies were confidently identified in error-tolerant absolute mass search. These data 
suggested that OmpT peptide-based analysis can provide isoform-specific assignments, 
characterization of modified peptides and combinatorial PTM information that may not be easily 
accessible by other protease-centered proteomic approaches. 
 
3.3.4 - OmpT substrate specificity under denaturing conditions 
Although the substrate specificity of OmpT has been extensively studied, previous model 
substrates were mostly short peptides and unstructured protein linker regions (14-16). This study 
helped to improve our understanding of OmpT's sequence preference under denaturing 
conditions (3.2 M urea) where whole proteins were the substrates. We searched the entire dataset 
in biomarker mode against an intact protein database. A biomarker search assumes no specific 
proteolytic cleavage, but rather queries every possible sub-sequence in the database within 
tolerance from an observed peptide mass. Confident biomarker peptide hits were then used to 
83 
extract the P4 through P4' recognition sites of OmpT for the generation of an unbiased consensus 
sequence. From these data, I generated an iceLogo (17) that normalizes observed amino acid 
frequencies at each site to a reference set of proteomic amino acid frequencies (Figure 3.6a-c). I 
also made a WebLogo (18) for comparison, which illustrates amino acid frequencies at each site 
solely based on the input sequences without normalization (Figure 3.6d). 
As shown in iceLogo and WebLogo representations, the P1 site was restricted almost 
exclusively to lysine and arginine, while the P1' site was more permissive, allowing 
predominantly lysine and arginine, but also alanine and serine. The relative promiscuity of 
OmpT at the P1' position may be attributed to the location of P1'-substrate binding site near the 
loops on top of the beta-barrel (7), which could have increased flexibility under denaturing 
conditions. Because of OmpT's broader specificity at the P1' site, I defined the "major cleavage 
sites" as K/R─K/R/A/S and performed another in silico digestion of human proteome at all these 
major sites assuming 0 and 2 missed cleavages (OmpT2 in Figure 1.1). The resultant peptide 
size distributions strongly resembled the distributions assuming only K/R─K/R cleavages. 
In addition to selectivities at the P1 and P1' sites, the P2' site also had a slight preference 
for aliphatic amino acids. Overall, OmpT favored positively charged residues across its 
recognition sites (with the exception of P2) and resisted negatively charged and proline residues. 
Selectivities outside P1─P1' have been previously reported (14, 15, 19) and might explain the 
average number of observed missed cleavages (0.99 1.29) at the major sites. In spite of these 
preferences, OmpT is still a stringent protease with well-defined substrate specificities, which 
will be better understood with future experimentation and data mining. 
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3.4 - Discussion 
Although this high-mass HeLa middle-down study is only the first initial trial to use 
OmpT on a complex proteome sample, it has profound influence and provides important insights 
in several aspects:  
First, this high-mass HeLa middle-down work proved the feasibility of OmpT to digest 
not only several standard proteins, but also complicated proteomic samples, and the 
compatibility of OmpT digestion with GELFrEE-coupled top-down pipeline via several 
precipitation and resuspension procedures. 
Second, it is notable that the over a thousand proteins identified are from merely a subset 
of the whole HeLa proteome. So by decreasing the crosslinking in the primary GELFrEE device 
(8% T and 10% T were used in this study), significantly better separations are achieved above 
100 kDa, making this very high mass proteome accessible for OmpT digestion. This indicates 
that even with the current middle-down setup, the sheer number of protein identifications from 
the entire proteome should be predictably more than a thousand. Considering that middle-down 
is essentially using top-down methodology (hi-hi data acquisition in particular) to measure large 
peptides (20), whose size is arguably close to intact proteins as in top down, the depth and 
sensitivity of middle-down approach is indeed in the same order of magnitude as top down. 
Third, this study offers a comprehensive understanding of substrate specificity of OmpT, 
especially when intact proteins are the substrates under highly denaturing conditions (3.2 M 
urea). As discussed in great detail in Results, the P1 position is strictly Lys or Arg (and a 2% 
chance for His as well, possibly because its side chains could be positively charged at pH 6.0); 
the P1' position has less stringent and allows other small aliphatic amino acids. This could be due 
to the presence of high concentration denaturant that makes the relatively exposed P1' binding 
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site more flexible. Additionally, there are preferences at other positions than P1 and P1', and 
hopefully with more data in hand, a deeper and more thorough understanding of OmpT's 
recognition site sequence can be attained. 
Fourth, the efforts in the development of custom informatics in this HeLa study not only 
enabled the identification of OmpT peptides in this case specifically, but also established a 
robust and reliable guideline for future informatic analysis of middle-down data from a given 
species. As long as adequate information about its genome or proteome sequences is available 
for intact database creation, biomarker search can be performed; after executing OmpT cleavage 
rules in silico on the intact databases, OmpT peptide databases can be generated for absolute 
mass search. 
On the other hand, what is beyond the scope of this chapter and may require further 
exploration in future involves several interesting and imperative topics as well. To start with, the 
reproducibility of OmpT digestion on complex proteome samples need to be validated, albeit the 
pattern of produced peptides from standard digestions seems quite reproducible. Also, the 
substrate specificity of OmpT need to be well characterized and evaluated, in order to create the 
ideal peptide database (21). Another related concern to the reproducibility is the ability of OmpT 
to perform quantitative proteomics, which is a grand subject and requires a significant amount of 
tests and trials before the formulation of a conclusion (22). Lastly, in spite that I found examples 
of proteotypic OmpT peptides, which demonstrates the capability of OmpT to provide 
biologically important information, a head-to-head comparison between OmpT and trypsin is 
certainly informative and helpful to showcase the exact extent, to which OmpT peptides can 
provide biological information complementary to tryptic peptides. 
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The above wraps up what has and has not been achieved in this chapter; below, I will talk 
about the technical aspects and places for improvement of this OmpT-base middle-down 
platform. There are several technical comments to make first. The primary GELFrEE is indeed 
not necessary for proteome-wide digestion and analysis. The only reason I used it in this study is 
I wanted to focus on the high-mass region specifically. The secondary GELFrEE serves the 
purpose of further fractionation and helps to remove the detergent (DodMe2NPrSO3, which gave 
an interfering peak on LC-MS/MS if samples were cleaned up directly using methanol-
chloroform precipitation) well, but it is not the only way to separate OmpT peptides prior to 
online nanoLC-MS/MS. Regarding the 8 M urea resuspension, as mentioned above, the sample 
loss during 8 M urea resuspension of the precipitated GELFrEE fraction pellet is unnoticeably 
low based on silver staining assay. But to assess the recovery rate more accurately, it necessitates 
more recovery tests across all mass ranges, because urea resuspension of protein substrates after 
primary GELFrEE seems to be an indispensable step in order to apply OmpT digestion. Finally, 
methanol-chloroform precipitation was used twice in the current middle-down platform, which 
works efficiently to remove SDS for MS analysis. But it might introduce sample loss as well 
(23), because some small peptides may not precipitate well and peptides soluble in methanol 
may get washed away in methanol wash steps. 
In terms of potential improvement of the current platform, there are quite a few items 
that, if resources and efforts are invested, can definitely boost the OmpT-based middle-down 
performance. 
First, the frontend sample handling should be minimized and can be shortened in the 
current setup to avoid sample loss and oxidation. Like mentioned before,  the primary GELFrEE 
is not necessary for full proteome digestion. The omission of this step can save two acetone 
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precipitation steps and one resuspension step using commercial GELFREE loading buffer. If 
alternatives are available and work equally efficiently in separation and detergent removal, the 
secondary GELFrEE is replaceable too, which will save two resuspension steps by SDS-PAGE 
sample loading buffer and nanoLC buffer A respectively, and one methanol-chloroform 
precipitation step. 
Second, improved separation protocol and next and new generation instruments with 
faster sequencing speed will undoubtedly help. An example was selected to show the complexity 
of a typical survey spectrum even after secondary GELFrEE and online LC separation (Figure 
3.7). Unlike the case in bottom-up, hi-hi data acquisition strategy and ProsightPC search engine 
allows the identifications of multiple precursors in the same isolation window for fragmentation 
event (24). At the same time, ETD is a promising technique in fragmenting large highly charge 
species (25) and presents high complimentarily to CID as shown the Results. So if effective one- 
or multiple-dimensional online LC, fast sequencing instrument and fragmentation methods (26) 
are properly chosen and combined, OmpT peptide-centric middle-down may experience a leap in 
performance. 
Third, the current digestion conditions may not be ideal, for a couple of reasons. First, 
different types of detergents used in the digestion system were not evaluated yet. One literature 
reported that OmpT's activity was highest in Tween 20, not DodMe2NPrSO3, according to small 
peptide activity assay (27). Second, even if 3 M urea was present in the OmpT digestion solution 
and it seemed to be enough to facilitate the denaturation and digestion of all four standard 
proteins, it is still worth the efforts to examine if 3 M urea is enough to linearize all the substrates 
in a proteome. But the standard digestion already suggested that 3 M urea might be the highest 
OmpT can tolerate in the detergent system, while still being able to efficiently deplete protein 
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substrates. There might be ways to enhance OmpT's resistant to denaturant, one of them being 
integrating OmpT into a nanodisc (28), in which OmpT basically sit in an in vivo-like double 
layer membrane environment rather than a detergent-made micelle.  
Fourth, the degraded OmpT peptide is a major interfering species on LC-MS. There are 
two possible ways to circumvent this issue. First, use less enzyme by elevating its proteolytic 
activity in 3 M urea. As previously discussed, choosing the optimal detergent may help to 
increase OmpT's activity in general; nanodisc may help to stabilize OmpT in high concentration 
urea. Second, immobilizing OmpT on bead or surface structure in a molecular cut-off column or 
filter format can separate the digested peptide from the immobilized protease conveniently (29). 
If this can be applied in combination with the nanodisc design, it will further benefit the 
downstream sample clean-up by confining the detergent within the nanodisc and minimizing 
detergent content in the digested sample solution. 
Last but not the least, the extensive engineering of the wild type OmpT has been reported 
to convert the enzyme into variants that cleave between different sites than di-basic sites (e.g. 
Glu-Arg, Tyr-Arg, Glu-Ala, etc.).  OmpT mutants have even been reported with kinetics up to 2 
orders-of-magnitude higher than wild-type enzyme (30-32). This provides a series of options to 
extend the initial work using wild type OmpT enzyme in this chapter. 
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3.5 - Figures 
 
Figure 3.1: OmpT-based platform for middle-down proteomics. The middle-down workflow 
was illustrated on proteins from a HeLa cell lysate sorted into narrow size ranges by molecular 
weight–based prefractionation (silver-stained gel, top right). A representative OmpT digestion of 
a fraction containing 50- to 75-kDa proteins (highlighted in the red box) was visualized by silver 
staining (left lane, bottom right) along with the control sample with no digestion (right lane). The 
digested samples were separated further, and fractions smaller than ~15 kDa were subjected to 
nanoLC-MS/MS analysis. This figure is adopted from the paper "A protease for 'middle-down' 
proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012) with modifications. 
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Figure 3.2: Representation of a typical nanoLC-MS/MS analysis of a secondary high-
resolution GELFrEE fraction. (a) Base peak chromatogram of the nanoLC-MS/MS run of a 
secondary GELFrEE fraction highlighted in d. (b) Primary continuous tube-gel electrophoresis 
fraction before OmpT digestion. (c) The same sample after OmpT digestion. (d) The digested 
samples fractionated by secondary continuous tube-gel electrophoresis. (e) Three selected OmpT 
peptide species on precursor scans with indicated monoisotopic masses and charge states. (f) 
Fragmentation spectra of the three corresponding precursors. Also shown are the identified 
proteins these OmpT peptides are derived from along with their q values. This figure is adopted 
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Figure 3.2 (cont.) from the paper "A protease for 'middle-down' proteomics", Wu, C., et al. Nat. 
Methods. 9, 822-824 (2012). 
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Figure 3.3: OmpT peptide size distribution, comparisons of two search modes and two 
fragmentation methods. (a) Mass distribution of identified OmpT peptides (below ~15 kDa) in 
comparison with that of tryptic peptides (33). (b) Comparison of OmpT peptide hits from 
absolute mass and biomarker searches. (c) In the Venn diagram on the left side, OmpT peptides 
from three secondary GELFrEE fractions were respectively injected onto nanoLC-MS/MS using 
a data-dependent top 3 method with alternating CID and ETD on the same precursors in a single 
run. In the Venn diagram on the right side, each of the same three secondary GELFrEE fractions 
were injected twice onto nanoLC-MS/MS, using CID or ETD respectively in a data-dependent 
top 5 method. Biomarker and absolute mass search hits at 1% FDR were pooled from each 
fragmentation method for the above comparisons. This figure is adopted from the paper "A 
protease for 'middle-down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012). 
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Figure 3.4: Examples of proteotypic OmpT peptides leading to isoform-specific 
assignments. (a) Cleavage sites are shown for each identified OmpT peptide. The isoform 
alignments are schematic on top, where different sequence regions between isoforms are marked 
between the dashed lines. Peptides covering the distinct part of a certain isoform are shaded in 
dark; peptides covering the common regions of all isoforms are in grey. Fragment maps of two 
OmpT peptides from lactate dehydrogenase A chain isoform 1 are shown along with their 
locations in the isoform, sizes and q values. Peptides 1 and 2 (10.8 kDa and 5.4 kDa 
respectively) cover a proteotypic sequence region of one L-lactate dehydrogenase A chain 
Figure 3.4 (cont.) 
(cont.) 
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Figure 3.4 (cont.) isoform 1; identified OmpT peptides cover the entire isoform-1 sequence. 
Detailed sequence alignments are shown below the peptide fragment maps, with peptides 1 and 2 
highlighted in red and their cleavage sites marked in bold blue. (b) Peptide 3 (9.8 kDa) leads to 
the specific identification of isoform A1-A of heterogeneous nuclear ribonucleoprotein A1. The 
sequence coverage of this isoform is 98%. This figure is adopted from the paper "A protease for 
'middle-down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012) with modifications. 
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Figure 3.5: Proteotypic OmpT peptides harboring multiple PTMs. (a) The 84-kDa heat 
shock protein Hsp90β (UniProt accession code P08238) identified by peptides in gray as shown 
in the schematics; peptide 1 contains two phosphorylations (P) sites as illustrated. Peptide 
information about their locations in the protein, sizes and q values are also listed. The fragment 
map of peptide 1 is shown on the lower left; the survey spectrum of the singly and doubly 
modified species on lower right. (b) Peptide 2 from eukaryotic translation initiation factor 5A-1 
(UniProt accession code P63241) contains an N-terminal acetylation and a hypusine as shown in 
the graphic. (e) Peptide 3 was identified with two di-methylated arginines from 40S ribosomal 
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Figure 3.5 (cont.) protein S10 (UniProt accession code P46783). This figure is adopted from the 
paper "A protease for 'middle-down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012) 
with modifications. 
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Figure 3.6: Amino acid frequencies at P1 and P1' sites, iceLogo and WebLogo of OmpT 
recognition consensus sequence. (a) 1,776 peptides with mass difference smaller than 10 ppm 
from biomarker search were used to extract the P4─P4' sequence of every OmpT cleavage site. 
The sequences were imported into iceLogo software (http://code.google.com/p/icelogo/) (17, 21) 
as a positive set (experiment set in the chart) and compared with a negative control set (static 
reference set in the chart, default “Swiss-Prot means" of Homo sapiens option indicated in the 
software). The frequencies of each amino acid at P1 position from both the positive set 
(experiment set) and negative set (static reference set) are shown in red and black bars in the 
chart respectively. The blue error bars in the static reference set show the confidence intervals, 
which are calculated using the Wichura algorithm with a user-defined p-value. In this case, p-
value is set as 0.01 and the corresponding confidence interval is [-2.58σ; 2.58σ] where σ is the 
standard deviation(17). (b) Chart of frequencies of each amino acid at P1' position. (c) An 
iceLogo presentation of the same amino acid frequency differences as a and b in percentage (y 
axis) at each position. (d) The same set of P4─P4' sequences were imported into online 
WebLogo application to generate a WebLogo of consensus sequence for OmpT cleavage site 
P1' P4 P3 P2 P1 P2' P3' P4' 
d 
Figure 3.6 (cont.) 
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Figure 3.6 (cont.) (http://weblogo.berkeley.edu/logo.cgi) (18) as a comparison to the iceLogo in 
c. This figure is adopted from the paper "A protease for 'middle-down' proteomics", Wu, C., et 
al. Nat. Methods. 9, 822-824 (2012). 
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Figure 3.7: A typical online nanoLC-MS scan of OmpT peptides from a secondary 
GELFrEE fraction. The area in red rectangle in the top panel is zoomed out on the bottom 
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Figure 3.7 (cont.) panel to show the complexity of the typical OmpT peptide spectra with most 
of the charges states of the peptide species labeled. 
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CHAPTER 4: APPLICATION OF MIDDLE-DOWN PROTEOMICS TO THE 
COMPARISON FROM MOUSE BRAIN PROTEOMES OF TWO INBRED MOUSE 
STRAINS 
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4.1 - Introduction 
In Chapter III, an OmpT-based middle-down proteomic pipeline was established and the 
first trial of this platform was also performed using high-mass HeLa cell proteome. The initial 
results from the HeLa study suggested that the size of OmpT peptides were at least three times as 
large as tryptic peptides and the large size may facilitate the isoform-specific identifications and 
characterization of combinatorial PTMs simultaneously (1). However, such potential benefits of 
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OmpT peptide-centric platform have not been demonstrated on real complex biological samples 
yet. 
One of the research interests in Sweedler group has been the neuropeptide discovery in 
mouse and rat brain tissues, which focuses on the identification and quantification of secreted 
metabolites and neuropeptides under various conditions, even at single cell scale (2). While it is 
biologically interesting to figure out what type of signals are being released to the outside of a 
cell, knowing the cellular contents of the cells responsible to the signal secretion and the target 
cells receiving such signals is equally important and intriguing. Information acquired from the 
peptidomics of neuronal cells or tissues can be complemented by the proteomics of such tissues 
to better understand the neural system. For example, not only the signal itself, but also the 
receptors of secreted signal on or within the recipient cells affects the final biological output and 
the receptors may vary significantly at different regions of the same brain, among individual 
mice or across different mouse strains (3, 4). Therefore, understanding which variants of the 
receptor are actually expressed and present for signaling in a given sample is essential to the 
comprehension of the signal readout. Hopefully, OmpT-based middle-down approach can 
provide such information from a proteomics perspective. 
Peptide-centric proteomics already came into play in a wide range of large-scale surveys 
on tissue-specific proteomes, such as liver, heart and brain (5-8). Also, tailored protocols have 
also been developed to isolate, characterize and quantify a peculiar region of mouse tissue 
proteome like synapses, hippocampus and suprachiasmatic nucleus and so forth (9-12), or a 
subset proteome, such as mouse brain plasma proteins that has been biased against by 
conventional techniques (4, 10, 11), or proteins that contain a specific type of PTM of interest 
like phosphorylation and glycosylation (7, 13-16). Moreover, particular regions of subcellular 
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organelles from a certain tissue, for instance, mitochondrial inner membrane in mouse liver, were 
also targeted for isolation and investigation in detail (17). While these studies would generate 
hundreds to thousands of protein identifications with ease from an array of mouse tissues, the 
proteomic distinctions among different mouse strains have yet been examined systematically. 
Therefore, I applied the newly established middle-down platform to investigate the 
proteomic differences between inbred mouse strains. Inbred mouse strains have long been 
utilized not merely in proteomics, but mostly as one of the most common in vivo model 
organisms in biology. Recently, the genome sequences of 18 inbred mouse strains have been 
published (18-22), providing us a reliable and valuable information source to create strain-
specific protein databases. At the same time, as opposed to collaborative cross mice (23) 
(http://csbio.unc.edu/CCstatus/index.py), the homozygosity of inbred mice reduces the proteome 
complexity and difficulty in downstream data interpretation. Last but not the least, a wealthy 
knowledge pool about the phenotypes of these inbred mice has been accumulated and is readily 
available (http://phenome.jax.org/). So if some cross-strain differences could screened out via the 
novel middle-down approach and could be correlated with some interesting phenotypes, the 
efficacy of this OmpT-best pipeline to deliver biologically meaningful information will be 
convincingly demonstrated. 
In this chapter, we first created a series of strain-specific ProSight databases through the 
collaboration of a group of colleagues. Then I performed high-mass middle-down studies on the 
two inbred mouse strains, C57BL/6J (the reference strain) and DBA/2J, which led to the 
discoveries of several SNPs from DBA/2J. This work enabled a well-rounded evaluation of the 
depth and width of middle-down platform can reach in a complex tissue context. It is also well 
worth mentioning that a diversity of comparisons can be done between inbred mouse strains 
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under various conditions, for example, at multiple ages, under drug treatments or by gender. The 
mouse brain samples at such conditions have indeed been prepared and can be easily repeated for 
biological replicate experiments. So this work laid a solid foundation for future follow-ups, 
where comparisons of inbred mouse strains under different conditions can be further investigated 
via both improved middle-down (discussed in Chapter III) and top-down approaches. 
 
4.2 - Experimental procedures 
Mouse brain proteome extraction. Briefly, frozen mouse brains (one brain from each 
strain respectively) were thawed on ice from -80˚C first. At the same time, FPS buffer (Focus 
Total Proteome Kit from Genotech) was mixed with EDTA-free 1× protease inhibitor for tissue 
lysis. To each brain, 3 mL of FPS buffer was added. Then homogenize the FPS and brain tissue 
mixture for 30 seconds for 5 cycles. After each cycle, the tube was chilled on ice for 2 min. 
before the next cycle. Homogenate was then transferred to a TA100 tube (Beckman-Coulter), 
balanced and spun down at 40,000 × g for 60 min. at 4˚C in a TA100 rotor using a Beckman 
100XL ultracentrifuge. After ultracentrifugation, the supernatant of the homogenate was saved 
into a 40 mL centrifuge tube (Polypropylene Oakridge, Nalgen). The volume of the supernatant 
was brought up to 20 mL by the addition of water. To this solution, 20 mL prechilled 20% 
trichloroacetic acid (TCA) was added to precipitate proteins in the solution. The mixture was 
vortexed thoroughly and incubated on ice for 30 min., before the protein pellet was spun down  
at 30,000 × g (20,000 rpm) for 30 min in a Sorvall SS-34 rotor via a Sorvall RC-5C. The 
subsequent supernatant was discarded and the pellet was washed twice with acetone : ethanol 
(1:1 by volume ratio), followed by two washes in acetone. The pellet was then air-dried before 
frozen in -80˚C for further experiments. 
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Primary GELFrEE, sample clean-up, secondary high-resolution GELFrEE and 
nanoLC-MS/MS. The whole middle-down protocol was the same as described in Chapter III as 
well as in the published paper (1). The only two differences from previous procedure were the 
sample resuspension and treatment prior to the primary commercial 8% T GELFREE, and data 
analysis after data acquisition (described in detail below). To resuspend the precipitated mouse 
brain proteome, the sample from -80˚C was resolubilized in ~5 mL lysis buffer (4% SDS, 10 
mM DTT and 100 mM Tris-HCl, with 1 × protease inhibitor cocktail, phosphatase inhibitors and 
sodium butyrate at pH 7.5) at 100˚C for ~ 10 min. Because of the usage of custom GELFrEE, the 
protection of cysteine side chain was necessary to avoid acrylamide adducts. So after the entire 
pellet was dissolved, 25 mM final concentration of iodoacetamide was added for alkylation of 
cysteine side chain. The mixture was incubated for 20 min. in dark. The proteins were then 
precipitated with 4 volumes of cold acetone at -20˚C for at least 30 min. up to overnight, 
resuspended in commercial GELFREE sample loading buffer supplemented with 4% SDS at 
100˚C for loading onto the primary GELFrEE device for fractionation. Based on BCA assay 
right after the alkylation step, the total amount of proteins that was extracted from each mouse 
brain and got resuspended after TCA precipitation was around 10 mg/brain. Half of the total 
proteome was loaded onto the primary GELFrEE device, while the other half was frozen at -
80˚C for future repeat experiments or top-down analysis. 
Databases and data searching. The sequenced genome information of strains C57BL/6J 
and DBA/2J from both Ensembl and Uniprot was compared using in-house algorithm. After 
comparison, the strain-specific SNP information was obtained and then included  in Swissprot-
compatible format files to create intact protein ProSight databases. These strain-specific intact 
databases were then digested in silico based on the defined OmpT cleavage rules to generate 
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OmpT peptide databases. The biomarker and absolute mass search parameters were the same as 
before (24) and in Chapter III. 
 
4.3 - Results 
4.3.1 - Mouse brain proteome extraction and primary GELFrEE separation 
A variety of mouse tissue total protein extraction protocols exist in previous literature 
(25, 26), as well as publicized company websites (e.g. http://www.piercenet.com/previews/2012-
articles/neuronal-protein-extraction/). But the fundamental idea is the similar - homogenization 
of dissected brain tissues in protein extraction solutions, mostly containing strong solubilizing 
reagents. The amount of total proteins extracted using the previous protocols ranged from ~30 
mg to ~100 mg. The protein pellet after TCA precipitation was resuspended in lysis buffer and a 
small portion (25 μL) of the total ~ 5 mL was used to measure the protein concentration via BCA 
assay. The 25 μL solution was precipitated by cold acetone first to remove interfering molecules 
and then resolubilized in 4% SDS for BCA assay. The amount of proteins extracted using the 
protocol developed in this study was at least 10 mg. About half of the total extracted proteome 
was used for primary GELFrEE separation to obtain high-mass proteome for middle-down 
analysis. While the primary commercial GELFREE does not introduce acrylamide adducts, the 
secondary custom GELFrEE does cause artificial acrylamide adducts on cysteine side chains if 
not protected. Therefore, iodoacetamide alkylation was performed after lysis buffer 
resuspension. After alkylation, in order to load the whole brain proteome onto commercial 8% T 
GELFREE cartridge for primary separation, the samples were precipitated again to be 
reconstituted in commercial GELFREE sample loading buffer supplemented with 4% SDS at 
100˚C to ensure complete resolubilization. The results of primary separation of brain proteomes 
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from both strains were shown and high-mass proteomes from ~ 15 kDa up to ~ 150 kDa were 
collected for the next-step OmpT digestions (Figure 4.1). 
 
4.3.2 - Strain-specific database creation 
A series of strain-specific databases were created thanks to a group of colleagues (Figure 
4.2). It should be pointed out that only SNP was considered when comparing the genome 
sequence for cross-strain differences, and gene insertion or deletion was not taken into account 
since it will change the coordinate of the protein sequences when creating the protein databases 
and complicate the database creation. As shown on the cluster database list, databases with 
strains names "c57" or "dba" designate databases for strains C57BL/6J and DBA/2J respectively. 
C57BL/6J databases were created as reference databases. Names with "CAM" indicated that the 
cysteine residues in those databases had been modified in silico to carbamidomethylation 
cysteine for alkylated data searching. "Decoy" databases were also generated by shuffling the 
sequences in the corresponding forward databases for FDR estimation. OmpT peptide databases 
containing "narrow" or "wide" denote different OmpT cleavage rules respectively while creating 
these peptide databases. For "narrow", the cleavage rule was that P1= K, R and P1'=K, R, A, S, 
G, V, I, L; for "wide" the cleavage rule was that P1=K, R, P1'=K, R, A, S, G, V, I, L, T, Q, N, H, 
F and P2'= V, L, A, I, K, F, S, G, Y, T, E, R, M. Database names containing "July" mean that the 
variants (with SNPs) of a basic sequence were all compiled into one entry, making the size the 
databases smaller and search speed faster, and this also allowed those variant sequences to be 
queried in biomarker search mode. 
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4.3.3 - Middle-down proteomic comparison of strains C57BL/6J and DBA/2J 
The high-mass proteome fractions 2-14 (~15-150 kDa) of both strains from primary 
GELFrEE separation were precipitated by cold acetone and digested by OmpT (Figure 4.3). 
These digested samples were then precipitated by methanol-chloroform method (27) and 
separated by secondary high-resolution GELFrEE (Figure 4.4). Secondary fractions below ~15 
kDa were cleaned up by methanol-chloroform precipitation (27) and subjected to nanoLC-
MS/MS characterization. 
After combining the peptide hits from both biomarker and absolute mass searches, 1934 
unique peptides (average size: 6.0 kDa) from 714 proteins were identified from strain C57BL/6J. 
The p score cut-off for biomarker search at 1% FDR was 1.89×10
-22
; the p score cut-off for 
absolute mass search at 1% FDR was 4.44×10
-12
. From strain DBA/2J, 1,855 unique peptides 
(average size: 6.0 kDa) were identified from 690 proteins. The p score cut-off for biomarker 
search at 1% FDR was 5.83×10
-21
; the p score cut-off for absolute mass search at 1% FDR was 
3.33×10
-12
. The histograms of identified OmpT peptide size from both strains were generated to 
illustrate the distribution difference between OmpT peptides and tryptic peptides (Figure 4.5). 
The master OmpT peptide lists for both strains were attached in Appendix C and D. 
In order to find strain-specific OmpT peptide identifications, the C57BL/6J databases 
were used as reference databases. Then the DBA/2J data set was searched against both DBA 
databases as well as C57 reference databases. The idea was that strain-specific peptides should 
only be identified by strains-specific database searching. Thus, after pooling the search hits from 
both databases, the repeat hits identified by both database searchings were manually removed, 
leaving only unique strain-specific peptide hits from the search results against DAB databases. A 
few such examples were shown with their strain-specific SNPs highlighted (Figure 4.6). 
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4.4 - Discussion 
The frontend sample preparation needs to be discussed to start with. First off, the mouse 
brain proteome extraction protocol used in this chapter underwent minimal optimization and may 
not be the ideal method to extract mouse brain proteome. The exact components of FPS buffer is 
unknown, but the best educated guess is that it is mainly composed of detergent and urea for 
protein solubilization. Because of the possible presence of urea, no heating process was involved 
during this extraction and after ultracentrifugation. Insoluble pellet could be readily seen at the 
bottom, indicating potential protein loss during brain proteome extraction process. Furthermore, 
multiple precipitation and resuspension steps were introduced for various reasons. For example, 
the proteome pellet after TCA precipitation was resuspended for cysteine alkylation; the 
alkylated samples were precipitated, and then resuspended again in GELFrEE sample loading 
buffer for primary separation. Indeed, ~ 10 mg of total protein extracted from a whole brain of an 
adult mouse was at the low end of the reported range (from ~ 20 mg up to ~100 mg). Another 
concern is that membrane proteins abound in brain tissues; so evaluation of membrane protein 
loss during extraction might provide better hints on how much bias this extraction protocol might 
have introduced. 
Second, as mentioned above, there were several precipitation and resuspension (at 
temperature as high as 100˚C) steps involved before the primary GELFrEE. This might cause 
undesired sample degradation and oxidation. If the proteome extraction buffer is compatible with 
iodoacetamide alkylation, or the downstream secondary custom GELFrEE can be substituted for 
by other means (discussed in Chapter III), then these precipitation steps can be avoided. 
Hopefully, this will help minimize the sample loss during sample preparation. 
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Since now two sets of data are available from two different biological systems, it would 
be interesting to compare the scales of proteome coverage in this cross-strain middle-down 
comparison project versus the HeLa middle-down study. In total, around 2,000 unique OmpT 
peptides were identified from over 700 proteins from each strain, in contrast to 3,697 OmpT 
peptides from 1,038 proteins from the HeLa study. So the overall performances between the 
HeLa and the mouse brain studies is at a similar scale, whereas the HeLa data set seems to be 
better than mouse brain data. There are a couple of factors that may contribute to relatively less 
identifications in the latter: 
To start with, although the initial sample loading amount for mouse brain project was 
theoretically ~5 mg, I noticed that a significant portion of the loaded protein samples didn't go 
through the commercial GELFREE cartridge, thus not collected in the collection chamber at all. I 
estimated the protein amount to be 2 mg based on BCA assay, which got lost in the loading 
chamber and didn't get into primary GELFrEE tube gels for fractionation. In other words, about 
only half of the loaded proteins actually went through the GELFrEE cartridge, and were 
collected and used for downstream digestions and MS analysis. So the actual amount of proteins 
that were analyzed by LC-MS/MS was less than that of the HeLa samples. This should be the 
major reason for decreased identification numbers. As far as why the samples were not be able to 
go through is not clear yet, but I tried decreasing the supplemented SDS concentration to 2% 
from 4% and removing the β-mercaptoethanol component that was supplemented into the sample 
loading buffer completely, and it seemed to significantly help to eliminate the retained proteins 
in sample loading chamber. 
On the other hand, in addition to LTQ-FT, Velos Orbitrap Elite was also used for ten 
injections in the HeLa study; but only LTQ-FT was used for the mouse brain study. Also, ETD, 
117 
known to be a complementary fragmentation method to CID, was used on the Velos Orbitrap 
Elite system in the HeLa study, but not in the mouse brain study. The identifications from Velos 
Orbitrap Elite contributed to 10% of the total number of identified HeLa proteins. This also 
suggested that next generation instruments will help to boost the number of identifications 
further (discussed in Chapter III). 
Lastly, as mentioned before, the primary GELFrEE served to provide high-mass 
proteome, which, although is peculiarly useful to specifically interrogate high-mass proteome, 
also introduces potential sample loss and can be omitted in this middle-down workflow. It also 
implies that if the whole proteome is to be analyzed as opposed to just high-mass proteome, the 
sheer numbers of protein identifications will be predictably higher. With all these factors taken 
into account, the scale of proteome coverage can possibly be even comparable to bottom-up 
proteomics, if sample manipulation and separation procedures are improved, and advanced 
instrumentation is implemented. 
Envisioning the future, the ultimate goal of such cross-strain comparison projects in 
discovery mode is to screen for some unknown targets to drill deep in focus mode for possible 
biological function implications. While I have found several interesting SNPs, both known and 
unknown, using the current middle-down pipeline, the chance to obtain more of such targets is 
unarguably optimistic, via either top-down or middle-down strategies. Additionally, due to the 
lack of consideration of gene insertion and truncation scenarios while creating those strain-
specific databases, more information can be explored and incorporated into the databases for 
searching. Ideally, top down or middle down will also become reliably quantitative to compare 
level changes of both proteins and PTMs among inbred mouse strains. 
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4.5 - Figures 
 
Figure 4.1: Primary GELFrEE separations of mouse brain proteomes extracted from 
strains C57BL/6J and DBA/2J. (a) Primary GELFrEE of mouse brain proteome from strain 
C57BL/6J. The collected fractions were numbered from 1 through 14 and only 10 ul out of the 
total ~1.2 mL fraction was loaded for SDS-PAGE and silver staining. Lane C, total brain 
proteome re-dissolved in commercial sample loading buffer prior to GELFrEE separation. (b) 
Primary GELFrEE of mouse brain proteome from strain DBA/2J. 
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Figure 4.2: Mouse strain-specific intact databases and OmpT peptide databases created for 
both biomarker and absolute mass searches respectively.  The strain-specific intact protein or 
OmpT peptide databases were highlighted in red rectangles. HeLa intact and OmpT peptide 
databases were highlighted in blue. 
Figure 4.2 (cont.) 
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Figure 4.3: Silver stained OmpT digestions of primary GELFrEE fractions from the two 
mouse brain high-mass proteomes. (a) OmpT digestion of fractions 2-14 from the primary 
GELFrEE separation of strain C57BL/6J brain proteome (Figure 4.1a) visualized on silver 
stained SDS-PAGE slab gels. Lane C, the high-mass substrate control from each corresponding 
fraction incubated in the absence of OmpT; Lane E, OmpT enzyme control incubated overnight 
without substrate. (b) OmpT digestion of fractions 2-14 from the primary GELFrEE separation 
of strain DBA/2J brain proteome (Figure 4.1b) visualized on silver stained SDS-PAGE slab 
gels. 
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Figure 4.4: Silver staining visualization of OmpT digestion products of high-mass 
proteomes from strains C57BL/6J (a) and DBA/2J (b) fractionated via secondary high 
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Figure 4.4 (cont.) resolution GELFrEE. Please note that Fractions 1-9 from each secondary 
GELFrEE separation were subjected to nanoLC-MS/MS analysis. 
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Figure 4.5: Size distributions of OmpT peptides identified from the two strains. (a) 
Histogram of identified OmpT peptides from strain C57BL/6J in comparison with typical tryptic 
peptide distribution (28). Please note that only OmpT peptides below ~15 kDa from the 
secondary GELFrEE fractions were analyzed via nanoLC-MS/MS in this study. (b) Histogram of 
identified OmpT peptides from strain DBA/2J in comparison with typical tryptic peptide 
distribution (28). 
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Figure 4.6: Examples of SNPs in strain DBA/2J discovered through the cross-strain 
comparison using the middle-down platform. (a) A 6.8 kDa OmpT peptide was identified 
with an leucine-to-isoleucine SNP in voltage-gated potassium channel subunit beta-2. The 
detailed peptide fragment map was shown along with the alignment between the canonical and 
observed sequences of that peptide. The SNP amino acid residue was highlighted in red. (b) A 
2.3 kDa OmpT peptide harbored a SNP from serine to glycine in zinc finger FYVE domain 
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Figure 4.6 (cont.) containing protein 19. (c) Microtubule-associated protein 1S contained a 
glutamine-to-arginine SNP, based on a 3.5 kDa OmpT peptide covering this region. This is a 
previously unknown SNP. 
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CHAPTER 5: UNCOVERING A GLOBAL RESISTANCE MECHANISM TO H2O2-
INDUCED APOPTOSIS IN YEAST USING FOURIER TRANSFORM MASS 
SPECTROMETRY-BASED YEAST HISTONE PROFILING PLATFORM 
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5.1 - Introduction 
Within the nucleus of a eukaryotic cell, its DNA is wrapped around a globular histone 
complex with the help of other non-histone proteins to form a nucleosome, which is the basic 
building block of chromatin. The core of a nucleosome is circled around by 146 base pairs of 
DNA, which is composed of two copies of four different histones, H2A, H2B, H3 and H4, to 
form a dimer of tetramer (1, 2). Besides, there are also flexible histone tails extending out of the 
core structure, and they are heavily modified by histone modifying enzymes in the formats of  
acetylation, methylation, phosphorylation, ubiquitination and so on (3). Different modifications 
have unique chemical effects on the interaction of the positively charged histones and negatively 
charged DNA molecules wrapped around. For example, acetylation neutralizes the positive 
charge on the lysine side chain, and thus decreases the charge interaction between histone and 
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DNA, loosening up the DNA bound around and providing more accessibility to this DNA region. 
On the other hand, methylation does not neutralizes but enhances the positive charges on lysine 
or arginines. Those PTMs and their combinations, referred to as the "histone code" (4), play an 
important role in the regulation of gene transcription (5), DNA repair and programmed cell death 
upon DNA damage and chromatin formation during cell division and death (6, 7). 
This chapter specifically focuses on the study of dynamic changes and correlations of the 
acetylation and phosphorylation on the core histones during apoptosis in yeast. Apoptosis is 
programmed cell death that is essential to various biological processes, such as development, 
differentiation and maintenance of cellular homeostasis in multicellular organisms. Stimuli both 
inside and outside of the cell can introduce DNA damage (e.g. H2O2-induce double strand DNA 
breaks), and thus apoptosis (8-10). One apoptotic phenotype among others at the early stage is 
the morphological change of chromatin from a relaxed into a condensed structure (typically 
visible on electron microscopy (11, 12)), indicating a complete shut-down of gene transcription 
activities. 
As for the reasons to use yeast model organism to study apoptosis, first of all, the four 
core histones, their modifying enzymes, as well as the key components of the apoptosis 
machinery are evolutionarily conserved from yeast to mammalian cells. Second, it has been 
showed that low dose H2O2 treatment induced yeast cell death similar to apoptosis in mammalian 
cells. Typical apoptotic phenotypes, such as phosphatidylserine externalization, chromatin 
condensation and DNA fragmentation (11), were shared in yeast cells, indicating that the study 
of PTM changes and relations in yeast apoptosis can also provide insights to the understanding 
of apoptosis mammalian cell. Third, due to the ease of gene knockouts in yeast compared with 
mammalian cells, those histone modifying enzymes, including histone acetyltransferases (HATs) 
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(6), histone deacytelases (HDACs) and etc., are readily available both commercially and from 
research labs. 
In terms of methodology, in order to investigate the full profile and the relative intensities 
of multiple PTMs simultaneously, which signify a variety of  biological function outputs (e.g. 
DNA repair and then cell survival, or cell machinery shut-down and cell death) during yeast 
apoptosis, top-down mass spectrometry came into play (13), thanks to its capacity to characterize 
intact proteins and the combinatorial patterns of their PTMs. A previous Kelleher group member, 
Dr. Lihua Jiang, established a robust yeast core histone extraction protocol and a characterization 
platform using top-down approach to profile PTMs on the four intact core histones via online 
LC-MS (13).  
Through the established platform, a series of HAT and HDAC yeast mutants were 
screened along with wild type as control, and their histone profiles were compared before and 
after H2O2-induced apoptosis. The following results are based on Dr. Lihua Jiang's thesis (data 
not published). A global massive decrease in acetylation level was observed on all histones upon 
H2O2 induction in wild type yeast and HAT mutants, such as gcn5∆, but not some of the HDAC 
mutants, including hos3∆, hda1∆ and rpd3∆. In contrast, the acetylation level of all histones in 
HDAC mutants remained the same as before treatment or even became hyperacetylated 200 min. 
after H2O2 treatment as in the case of rpd3∆ mutant yeast. At the same time, the survival rates 
after 200 min. H2O2 treatment correlated with the acetylation degrees on the histones. 
Hyperacetylated HDAC mutants had a higher survival rate compared with wild type yeast cells. 
Another intriguing finding was that the phosphorylation at Ser129 on H2A increase significantly 
in the course of 200 min. in the hos3∆, hda1∆ and rpd3∆ mutants. H2A phosphorylation has 
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been known to trigger DNA repair pathway by recruiting HAT machinery to acetylated histones 
(6, 14). 
Based on the observations above, we hypothesized that maybe the hyperacetylation of all 
histones in the HDAC mutants may help to counteract the collapse of chromatin, and thus allow 
the mutant cells more time to initiate DNA repair by Ser129 phosphorylation (3), which 
eventually leads to cell survival. 
My efforts to test the above hypothesis involves four aspects. First, I did a time course 
study on the dynamic changes of the acetylation and phosphorylation in rpd3∆ mutant cells along 
with wild type control. The purpose of this part is to further confirm the correlation between the 
acetylation states and the phosphorylation level on Ser129. Second, I did a time course survival 
assay in rpd3∆ mutant and wild type cells, to see if the acetylation and phosphorylation correlate 
with the survival rate as well. Third, I imaged the chromatin morphology using transmission 
electron microscopy (TEM) in both rpd3∆ mutant and wild type cell nuclei, looking for evidence 
that the hyperacetylation can indeed antagonize or  prevent chromatin condensation. Finally, in 
collaboration with Professor Jef Boeke lab, I obtained rpd3∆ mutant yeast cells with the H2A 
Ser128A or S128E mutations in the strain JDY78 and profiled their core histones, whose results 
are discussed further below. 
 
5.2 - Experimental procedures 
Yeast histone isolation. The yeast histone was isolated following the protocol described 
before (13). Briefly, Wild type and mutant cells from strain S288C or JDY78 (obtained from Dr. 
Junbiao Dai in Jef Boeke's lab) were grown in YPD (10 g Bacto Yeast Extract, 20 g Bacto 
Peptone, 20 g Dextrose in 1 L H2O) media to midlog phase with an O.D.600 at 0.6. Apoptosis was 
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induced with the addition of H2O2 to a final concentration of 1 mM. Cells were harvested by 
centrifugation. The cell pellet was then lysed with yeast protein purification reagent (Yper, 
Pierce) to deplete cytoplasmic proteins. After Yper extraction, the mixture of Yper and yeast 
cells was centrifuged to pellet histones, which were not extracted into Yper solution. Histones 
were extracted from the resultant pellet by 2.5 volumes of 8M urea and 0.4N sulfuric acid twice 
for 30 min. The supernatant after extraction was clarified by centrifugation and pooled, 
immediately followed by desalting using disposable C4 solid phase extraction column (J.T.Baker 
Inc. BAKERBOND spt
TM
 wide pore butyl). Histones were eluted off the column by 60% 
acetonitrile, 0.1% trifluoroacetic acid (TFA), dried down by SpeedVac. The samples thereafter 
were oxidized first using mild performic acid (3% formic acid, 3% H2O2) for 4 hours (15), and 
then subjected to online LC-MS analysis on a 7T LTQ FT. 
Online LC-MS. For the online LC, a 4.6 mm x 250 mm C8 Vydac column was used on 
an Agilent 1100 HPLC system. The mobile phases were buffer A (95% H2O, 5% ACN, 0.2% 
TFA, 0.1% formic acid) and buffer B (5% H2O, 95% ACN, 0.2% TFA, 0.1% formic acid). 
Gradient used was slightly different from previously reported (13), which started at 0% buffer B 
(95% H2O, 5% ACN, 0.2% TFA, 0.1% formic acid), went up to 10% buffer B in 10 min., then 
40% buffer B in 30 min., then to 65% buffer B in 50 min., then 70% buffer B in 20 min., then to 
85% buffer B in 35 min., and finally 100% buffer B in 15 min. For the MS method, a "zoom-
mapping" strategy was implemented, where precursor spectra were only scanned within a narrow 
m/z window. Specifically, an FT full scan was set as the first event to scan from 500-1,500 m/z, 
followed by four MS2 scans with 0% CID collision energy and a 60 m/z isolation window 
scanning the ranges of 790-850, 840-900, 890-950 and 940-1,000  m/z respectively. AGC targent 
value was set at 1 million for both FT full scan and MS2. 
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Yeast plate survival assay. Yeast cells were cultured the same as described above in a 
smaller scale (50-100 mL culture), and treated with H2O2 to a final concentration of 1 mM for 
different durations. Then yeast cells were pelleted, washed quickly and briefly by DI H2O twice, 
and then plated on the solid YPD agar plates at different dilution factors. Plated cells were 
incubated at 30°C till the colony sizes were proper and the whole plate was scanned for pictures. 
Yeast cell preparation for TEM imaging of condensed chromatin. The preparation of 
yeast cells for TEM imaging followed a protocol as previously described with some minor 
modifications (9, 11, 12, 16, 17). Briefly, yeast cells were cultured and treated in small scale as 
mentioned above. Then cells were harvest and washed quickly with Sorenson's buffer (to make 
100 ml Sorenson's buffer, mix 28 ml of 0.2 M mono sodium phosphate and 72 ml of 0.2 M 
dibasic sodium phosphate) before fixed on ice for 30 min. in prefixation solution consisting of 
2% glutaraldehyde in Sorenson's buffer The cell walls of fixed yeast cells were removed by 
lyticase (Sigma-Aldrich) in 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 1.4 M sorbitol, and 0.44% 
(v/v) 2-mercaptoethanol. The cell walls were digested for ~ 15 min. before washed in Sorenson's 
buffer again, resuspended in prefixation solution and submitted to the Center for Microscopic 
Imaging at University of Illinois, Urbana-Champaign for further processing and microscopy 
imaging. 
 
5.3 - Results 
5.3.1 - MS profiling of rpd3∆ core histones in the time course of H2O2 treatment 
Although a robust yeast histone extraction and profiling platform had been established 
previously (13), it was difficult to reproduce the results robustly shortly after I took over the 
project, due to the lack of the overlap and transfer of knowledge. I was able to demonstrate the 
136 
reproducibility well by obtaining the same results as acquired by previous group member solely 
based on the published protocol with some modifications (Figure 5.1). 
After streamlining the platform, I profiled the core histones in rpd3∆ during the course of 
H2O2 treatment, to further investigate the correlation between acetylation and phosphorylation 
(Figure 5.2). It is interesting to observe that particularly H2B and H4 experienced an overall 
decrease in acetylation from 0 min. to 30 min., but the acetylation level shifted back to 
hyperacetylation state at 90 min. and 200 min., which was in accordance to the increase of the 
phosphorylation level at Ser128 at 90 min. and 200 min.  
 
5.3.2 - TEM images of chromatin condensation and survival plate assay of wild type and 
rpd3∆ yeast cells 
To test our hypothesis that hyperacetylation may slow down or prevent the chromatin 
condensation during apoptosis, I developed a pipeline based on a previous protocol to image 
condensed chromatin in yeast nuclei with some modifications (9, 11, 12, 16, 17). After treating 
yeast cells at different time points, cells were harvest, washed and fixed prior to the subjection to 
lyticase digestion to remove cell wall. Based on the TEM images, the majority of rpd3∆ cells had 
a clear nucleus without condensed chromatin, compared with wild type cells (Figure 5.3a, b). 
On the other hand, there was still a small portion that represented similar phenotype to wild type 
and harbored readily visible condensed chromatin (Figure 5.3c). Given that chromatin 
condensation is an early indicator of apoptosis, this observation corroborates with previous 
findings where rpd3∆ cells had a higher survival rate (~50%) in contrast to wild type cells 
(~20%) (Dr. Lihua Jiang's thesis, unpublished). It is also noteworthy that the rest of the counted 
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rpd3∆ cells also had visible condensed chromatin as wild type cells, but at a lower rate (Figure 
5.3c). 
I also performed the survival plate assay of both wild type and rpd3∆ cells at different 
H2O2 treatment time points (Figure 5.4). Rpd3 cells had a higher survival rate than wild type 
cells across the tested time course, which also agreed with previous results of survival rates after 
200 min. H2O2 treatment (Dr. Lihua Jiang's thesis, unpublished). 
 
5.3.3 - Comparison of histone profiles of strains S288C and JDY78 and histone profiles of 
rpd3∆ + S128A and rpd3∆ + S128E double mutants in strain JDY78  
Since the global increase of phosphorylation on H2A in rpd3∆ cells after H2O2 treatment 
were localized to Ser129, which is known to help to recruit DNA repair machinery and 
eventually facilitate cells to diverge to survival from apoptosis. So we requested rpd3∆ + S128A 
and rpd3∆ + S128E double mutants from Jef Boeke's lab to examine the acetylation states of 
core histones after induced apoptosis and survival rates of these mutants. Because these double 
mutants are created in a slightly different yeast strain, JDY78, the reproducibility of the 
hyperacetylation and phosphorylation was examined upon H2O2 induction in rpd3∆ mutant in 
both strains S288C and JDY78. Surprisingly, the acetylation states and the phosphorylation were 
not consistent between the two yeast strains (Figure 5.5). While the acetylation states of H2B 
and H4 looked similar between the two at both 0 min. and 200 min., the extent of H3 acetylation 
was higher in JDY78 than S288C. Meanwhile, unlike strain S288C, there was no observable 
level of phosphorylation upon H2O2 treatment in rpd3∆ from strain JDY78 at 200 min. 
At the same time, initial histone profiles were obtained from rpd3∆ + S128A and rpd3∆ + 
S128E in strain JDY78 (Figure 5.6), which confirmed that the masses of histones with the 
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desired mutations are correct. While the acetylation states of H2B, H2A and H3 resembled rpd3 
mutant in the same strain, rpd3∆ + S128A had slight more H4s hyperacetylation than rpd3∆ + 
S128E. The differences in MS profiles between the two double mutant strains also indicated the 
potential issue of reproducibility of previous discoveries using a different strain. 
Lastly, I did plate survival assays on S128A and S128E single mutants from strain 
JDY78 (Figure 5.7). Similar survival experiment has been done before (14), but the purpose 
here is to verify that I was able to obtain the same phenotype in this specific strain as previously 
reported. It seemed like that the survival rate of S128E is higher than wild type and S128A. The 
survival rate of S128A was slightly lower than wild type after 200 min. H2O2 treatment but had 
similar rate after 60 min. treatment. Overall, this set of observations agrees with previous 
literature. 
 
5.4 - Discussion 
I mainly contributed in two aspects to support of the hypothesis proposed in 
Introduction. First, the dynamic profiling of core histones from in rpd3∆ mutant from strain 
S288C  illustrated the direct correlation between hyperacetylation and increased level of Ser128 
phosphorylation. Second, the visualization of condensed chromatin in yeast cell nuclei showed 
that wild type yeast cells had more condensed chromatin than rpd3∆ during H2O2-induced 
apoptosis. Combining the above two observations, it is suggested that hyperacetylation in rpd3∆ 
might play a role in preventing or slowing down the chromatin condensation to some extent, 
allowing the occurrence of phosphorylation on Ser128, which in turn recruits DNA repair 
machinery for following cellular events that eventually leads to cell survival instead of cell 
death. 
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It is noteworthy that the rdp3∆ histone profiles I collected from strain S288C (the same 
strain as before, but from different batches or ordered at different times) are somewhat different 
from previously observed profiles, although the general trend is similar. Specifically, the 
hyperacetylation level I observed at 0 min. on H2B and H4 are visibly lower than previous 
observation. Also, after 200 min. H2O2 treatment, the acetylation level of H3 indeed decreased 
noticeably, just like wild type H3, while the other histones remained mainly the same or only had 
a slight decrease. On the contrary, previous observation shows a hyperacetylation state on H3 
even after 200 min. H2O2 treatment. These differences imply that there might be some unknown 
factors, either technical or biological, that contributed to the altered observations. 
To further investigate the role of S128 phosphorylation in rpd3∆  mutant yeast, we 
obtained rpd3∆ + S128A and rpd3∆ + S128E double mutants. These mutants were constructed in 
a different but closely-related yeast strain, JDY78. Both the phenotypic traits such as growth rate 
(data not shown) and genetic background of histone genes differ between the two strain. A 
tremendous amount of efforts were dedicated to the study of the mutants in strain JDY78. 
However, it seemed like that most importantly, the hyperacetylation and phosphorylation at 
Ser128 in rpd3∆ single deletion cells could not be reliably and consistently reproduced across 
yeast strains to start with. In particular, the phosphorylation of Ser128 was readily detected in 
strain S288C, but was not observable in strain JDY78 after 200 min. H2O2 treatment. On the 
other hand, while the acetylation level on H2B and H4 looked similar between the two strains, 
H3 represented a hyperacetylation state after 200 min. H2O2 treatment in strain JDY78, but not in 
strain S288C. In addition, the acetylation states on rpd3∆ + S128A and rpd3∆ + S128E double 
mutants were not consistent in the first place, adding an extra layer of complexity, should further 
comparisons be carried out using these double mutants. Although the survival assay results of 
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S128A and S128E seemed to agree with previous findings within strain JDY78, the 
disagreements of histone PTM profiles in response to H2O2 treatment between the two strains 
became a serious issue to further test our hypothesis. 
141 
5.5 - Figures 
 
Figure 5.1: Base peak chromatogram, online LC gradient and the mass spectra of four core 
histones from wild type yeast cells profiled via the established platform. 
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Figure 5.2: Dynamic changes of all four core histones in rpd3∆ mutant cells after 1 mM 
H2O2 treatment. Note that the phosphorylation level changes on H2A during the time course 
along with the acetylation levels on the other core histones. 
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Figure 5.3: TEM imaging of condensed chromatin in wild type and rpd3∆ yeast cells. (a) 
Comparison of typical chromatin morphologies of wild type and rpd3∆ yeast cells at different 
time points of H2O2 treatment under low magnification power. The numbers of the cells that 
represent the same or similar morphologies are listed on the bottom right of each image. 0.5 μm 
scale bar is marked on the top left of each image. Arrowheads in the wild type image indicate 
readily visible condensed chromatin. (b) Comparison of typical chromatin morphologies of wild 
type and rpd3∆ yeast cells under low magnification power. 0.1 μm scale bar is marked on the top 
left of each image. (c) Image of the rest of the rpd3∆ cells after 200 min. H2O2 treatment, which 
show similar condensed chromatin to the majority of wild type cells, but only 14 of the 50 
randomly counted cells other chromatin resemble the chromatin morphologies, as opposed to 46 
of the 50 wild type cells counted. 
c 
Figure 5.3 (cont.) 
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Figure 5.4: Survival plate assays of wild type and rpd3∆ yeast after different lengths of 
H2O2 treatment. (a) Wild type yeast cell survival assay during 0-60 min. time course of H2O2 
treatment. (b) Rpd3∆ yeast cell survival assay during 0-60 min. time course. (c) Comparison of 
wild type and rpd3∆ yeast cell survival rates after 60 min. H2O2 treatment. 
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Figure 5.5: Comparison of the profiles of all four core histones in rpd3∆ mutants derived 
from strains S288C and JDY78 after H2O2 treatment at 0 min. and 200 min. Note the 
difference in phosphorylation level after 200 min. H2O2 treatment between the two strains 
(highlighted by red dashed line). Asterisk marks a concomitant irrelevant species. Also the H2B 
profile altered in the JDY78 strain because of the absence of one of the two H2B genes in this 
strain, resulting in single peak instead of duplex peak pattern. 
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Figure 5.6: The histone profiles of double mutants rpd3∆+S128A and rpd3∆ +S128E from 
strain JDY78. Note that there is an m/z shift in H2A peaks due to the mass change of the 
mutations from serine to alanine and glutamic acid respectively. Asterisk marks a concomitant 
irrelevant species. 
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Figure 5.7: Plate survival assays on wild type and mutants from strain JDY78 under H2O2 
induced-apoptosis. The same amount of yeast cells were plated on solid YPD plates by a series 
of dilution factors during the time course of H2O2 treatment. 
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CHAPTER 6: CONCLUSION 
 
Bottom up and top down are the two mainstreams to conduct mass spectrometry-based 
proteomics. While bottom-up approach involves enzymatic digestion of proteins of interest into 
peptides first prior to one- or multi-dimensional separation and MS analysis, top-down approach 
bypasses the proteolytic step and directly targets intact proteins, aiming for the detection and 
characterization of full length proteins. Bottom-up approach is impressively powerful in terms of 
protein identification, throughput and sensitivity, but the basic unit of measurement, tryptic 
peptides, is relatively small (<2 kDa on average), leading to potential issues such as sample 
complexity, protein inference problem and loss of PTM information and connectivities between 
PTMs. Top-down approach overcomes the above issues, but suffers performance decrease along 
the increase of protein size. Therefore, in this thesis, I proposed a hybrid middle-down approach, 
which combines the positive aspects of both approaches and relies on robust yet restricted 
proteolysis of a rare-cutting protease - OmpT. The idea is that because OmpT specifically 
recognizes and cleaves between less frequent dibasic sites in a proteome than trypsin, and 
possesses a reasonably high kcat/Km number, it can efficiently convert intact proteins into large 
peptides, which are larger than tryptic peptides, so that the digested samples would have reduced 
sample complexity and the resultant OmpT peptides would hopefully preserve more biological 
information. 
The first hurdle I leaped over was the successful expression and purification of the stable 
OmpT enzyme for the following work. This was the most rate-limiting step since there is a 
dibasic site within the enzyme sequence itself, the degradation of which would inactivate the 
proteolytic activity. A series of options were tested out and finally a protocol with several subtle 
tactics were developed to acquire stable protease. The two essential parts were the high 
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concentration salt solution to inhibit OmpT's activity after cation exchange purification and the 
addition of LPS prior to dialysis against enzymatic buffer. With a stable reagent in hand, I went 
ahead and optimized the digestion conditions of OmpT using four standard substrates, the 
digested products of which were also characterized via nanoLC-MS/MS. The observed OmpT 
cleavage sites based on confidently identified OmpT peptides provided us valuable information 
for understanding the substrate preferences of OmpT. 
After the optimization of OmpT digestion conditions, I established an OmpT-based 
middle-down proteomics platform by incorporating GELFrEE separation technique to 
interrogate high-mass HeLa cell proteome as the first trial. In this study, 3,697 unique peptides 
were identified from 1,038 proteins in the range of ~20-150 kDa with an average size of 6.3 kDa. 
Since OmpT peptides above ~15 kDa were not analyzed in this study, the actual average size 
would be even larger. Among the identified OmpT peptide hits, several proteotypic peptides 
were selected to demonstrate the ability of OmpT peptides to differentiate protein isoforms with 
only slight variations in their sequences and to preserve multiple PTMs on a single peptide. 
These data collectively suggested that this middle-down pipeline could provide complementary 
while meaningful biological information to traditional protease-based proteomic approaches. 
To further examine the feasibility of OmpT-based middle-down workflow in biologically 
interesting but complex tissue samples, I applied this platform to the cross-strain comparison of 
inbred mice from two different strains, C57BL/6J and DBA/2J. After the coordination of several 
research groups and thanks to the efforts from a collection of colleagues, we were able to build a 
series of strain-specific mouse databases for data searching and identification. Then I performed 
the middle-down analysis on the brain proteomes from two inbred strains and compared the 
identified OmpT peptides for cross-strain differences. Consequently, several SNP examples 
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unique in strain DBA/2J were found, proving the efficacy of the middle-down workflow to 
actually deliver insightful biological information at the proteomic level. 
Two thorough discussions were verbalized in the end of Chapters II and III to enumerate 
both the limitations and potential places for future improvements. In summary, the work 
described in this thesis was not the beginning of the end, but the end of the beginning, of the 
"middle-down era", if one doesn't object. It took trypsin several decades from initial trials as a 
protease to gain the world-wide popularity in the proteomics community as of today; it is not 
hard to imagine that the road for a new enzyme like OmpT toward prevalent acceptance by the 
community will be arduous and attritional.  
The last part of the thesis nimbly supports our proposed hypothesis about the global 
resistance mechanism to apoptosis upon the induction of DNA damage in yeast. The hypothesis 
was in HDAC deletion mutant yeast cells, the hyperacetylation states of all four core histones 
may help to prevent chromatin condensation upon H2O2-induced apoptosis, allowing more time 
for Ser129 to be phosphorylated, which would recruit the DNA repair machinery to the DNA 
damage loci for DNA repair, and in turn lead the yeast cell to commit cell survival to a larger 
extent than wild type cells that largely undergo apoptosis. I obtained the TEM images of both 
HDAC mutant (rpd3∆) cells and wild type cells and visualized the different degrees of chromatin 
condensation, which supported the part that the hyperacetylation might help to counteract or 
slow down the chromatin condensation and thus the complete shutdown of  cellular gene 
transcription events in our hypothesis. I also profiled the dynamic changes of all four core 
histones in rpd3∆ mutant cells, which illustrated the tight correlation between the acetylation 
states and the phosphorylation level on Ser129. A tremendous amount of efforts were also 
devoted to the further characterization of rpd3∆ + S129A and rpd3∆ + S129E double mutants in 
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another yeast strain both using top-down mass spectrometry, as well as plate survival assays, the 
results of which showed promiscuity, and were also described and discussed in robust detail. 
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APPENDIX A: IDENTIFIED UNIQUE OMPT PEPTIDE LISTS AND UNIQUE PROTEIN 
COUNTS FROM PROTEIN CENTER REPORT.  
Unique OmpT peptides identified from absolute mass and biomarker searches are listed 
separately as well as in a combined list after removing the redundant overlapped hits from both 
search mode. These tables are adopted directly from the Supplementary Table 1 of the paper "A 
protease for 'middle-down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012). Due to 
the length of the tables in this appendix, electronic version is provided instead of hard copy.
 
APPENDIX B: POOLED UNIQUE OMPT PEPTIDE IDENTIFICATIONS FROM THE 
NANOLC-MS/MS INJECTIONS FOR THE CID AND ETD COMPARISONS.  
These tables are adopted directly from the Supplementary Table 2 of the paper "A 
protease for 'middle-down' proteomics", Wu, C., et al. Nat. Methods. 9, 822-824 (2012). Due to 
the length of the tables in this appendix, electronic version is provided instead of hard copy. 
 
APPENDIX C: IDENTIFIED UNIQUE OMPT PETPIDE LIST AND UNIQUE PROTEIN 
COUNTS FROM STRAIN C57BL/6J. 
Unique OmpT peptides identified from absolute mass and biomarker searches are listed 
separately as well as in a combined list after removing the redundant overlapped hits from both 
search mode. Due to the length of the tables in this appendix, electronic version is provided 
instead of hard copy. 
 
APPENDIX D: IDENTIFIED UNIQUE OMPT PETPIDE LIST AND UNIQUE PROTEIN 
COUNTS FROM STRAIN DBA/2J.  
Unique OmpT peptides identified from absolute mass and biomarker searches are listed 
separately as well as in a combined list after removing the redundant overlapped hits from both 
search mode. Due to the length of the tables in this appendix, electronic version is provided 
instead of hard copy.
 
